{"meta":{"query_hash":"2ee2419f4287","filters":{"venue":"Journal of Immunotherapy"},"cohort_total":55,"direct_labels_cover":0,"predictions_cover":55,"exported":55,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2ee2419f4287","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Immunotherapy"},"results":[{"id":"W1127933869","doi":"10.1097/cji.0000000000000089","title":"Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents","year":2015,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Clinical trial; Oncology; Drug development; Cancer; Chemotherapy; Disease; Immunotherapy; Drug; Internal medicine; Pharmacology","score_opus":0.23698800890256355,"score_gpt":0.4567935504305351,"score_spread":0.21980554152797155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1127933869","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03113245,0.018671967,0.78791595,0.016488694,0.01853149,0.104591645,0.0020244636,0.0022081477,0.018435158],"genre_scores_gemma":[0.25040713,0.0021197114,0.5394667,0.00939649,0.0026945497,0.19078194,0.0006689203,0.0006174091,0.0038470675],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.1682175,0.77395284,0.024839068,0.008676295,0.02249832,0.0018160193],"domain_scores_gemma":[0.2823456,0.62608147,0.022082014,0.050163638,0.01558283,0.0037443899],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5990449,0.0024551349,0.009672779,0.0046529584,0.0024671662,0.0066920742,0.00502196,0.007165142,0.0083863],"category_scores_gemma":[0.7096819,0.0023175692,0.0064494377,0.008917159,0.009677283,0.0064087715,0.0045040036,0.013717164,0.0019466117],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1469065,0.001915509,0.027527435,0.026556065,0.029155286,0.0029868823,0.0050097825,0.05413063,0.0047142594,0.20370877,0.05908877,0.43830013],"study_design_scores_gemma":[0.03090828,0.034245014,0.021795545,0.008549755,0.0084962705,0.0014962995,0.0015454257,0.3155164,0.009268908,0.34868735,0.21885313,0.00063760154],"about_ca_topic_score_codex":0.0009325885,"about_ca_topic_score_gemma":0.00122302,"teacher_disagreement_score":0.5990449,"about_ca_system_score_codex":0.0044346284,"about_ca_system_score_gemma":0.00761524,"threshold_uncertainty_score":0.49444902},"labels":[],"label_agreement":null},{"id":"W1964404276","doi":"10.1097/cji.0b013e318207ed14","title":"Identification of T-cell Epitopes by a Novel mRNA PCR-basedEpitope Chase Technique","year":2011,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research","keywords":"Epitope; Messenger RNA; Molecular biology; Antigen; Polymerase chain reaction; Biology; CD8; T cell; Complementary DNA; Linear epitope; Virology; Computational biology; Gene; Immune system; Immunology; Genetics","score_opus":0.015970807546544178,"score_gpt":0.2423509917837237,"score_spread":0.22638018423717954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964404276","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19696276,0.0026000044,0.7964,0.00027177623,0.00018478888,0.00041706406,0.00029898496,0.00086070097,0.0020039312],"genre_scores_gemma":[0.38064143,0.004197224,0.6057105,0.00029277828,0.00017713619,0.0007275199,0.0011967674,0.00023039745,0.006826327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950933,0.00011153819,0.000041949217,0.00011928427,0.00015908324,0.000058793477],"domain_scores_gemma":[0.99959666,0.00017277079,0.00007439188,0.00006062454,0.00006618319,0.000029478775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005727371,0.00072303653,0.000528259,0.0004372371,0.00024744653,0.0005147279,0.0003972716,0.0005305983,0.00090331724],"category_scores_gemma":[0.000541497,0.00035836778,0.00039360166,0.00020314727,0.0004908618,0.0004051551,0.0004294702,0.0016311964,0.00083987677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000280126,0.000019142633,0.00006278975,0.000039874198,0.0000028664797,0.000037700935,0.00001149466,0.00006695181,0.9957962,0.00017859046,0.000027989367,0.0037283779],"study_design_scores_gemma":[0.000015081308,0.00020614934,0.00043809283,0.0000053608105,0.00001823666,0.00041211746,0.00000839282,0.002009923,0.99376845,0.000061794926,0.0030475778,0.000008847018],"about_ca_topic_score_codex":0.00024310418,"about_ca_topic_score_gemma":0.0005563447,"teacher_disagreement_score":0.00090331724,"about_ca_system_score_codex":0.0002189313,"about_ca_system_score_gemma":0.00034090594,"threshold_uncertainty_score":0.0030289888},"labels":[],"label_agreement":null},{"id":"W1970241155","doi":"10.1097/cji.0b013e318184908d","title":"Donor Regulatory T Cells Identified by FoxP3 Expression but Also by the Membranous CD4+CD127low/neg Phenotype Influence Graft-versus-tumor Effect After Donor Lymphocyte Infusion","year":2008,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"FOXP3; Medicine; IL-2 receptor; Malignancy; Immunology; Regulatory T cell; Interleukin-7 receptor; Population; Lymphocyte; Immunotherapy; T cell; Internal medicine; Immune system","score_opus":0.00569984326743634,"score_gpt":0.20977964559772558,"score_spread":0.20407980233028924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970241155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998609,0.00029472954,0.0004384281,0.000018409306,0.000009191823,0.000009606096,0.00001971432,0.00002729076,0.00057371514],"genre_scores_gemma":[0.99902844,0.00014993902,0.00032564043,0.000020365418,0.000009075074,0.00001007207,0.000054284945,0.000008023357,0.00039416944],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998599,0.000030085665,0.000008022449,0.000015710548,0.000025625433,0.000060666425],"domain_scores_gemma":[0.99982625,0.000049332866,0.0000373721,0.000017554748,0.00000905817,0.000060406557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020884207,0.00028290015,0.00031090647,0.00018543711,0.00008596728,0.00029091013,0.000126305,0.00013267923,0.0011130177],"category_scores_gemma":[0.0002714117,0.00008959326,0.00013332082,0.00007862346,0.00021898079,0.00015771724,0.00013501916,0.00067333644,0.00017511194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020470626,0.00081667106,0.0018495776,0.000056043045,0.000011053056,0.00013130068,0.000036586727,0.00020318141,0.97945833,0.00019252428,0.00012407196,0.015073595],"study_design_scores_gemma":[0.0003195935,0.008238987,0.013268738,0.00001642152,0.00008875671,0.00079244433,0.000058671652,0.0026713135,0.97280157,0.00024236624,0.0014916935,0.000009463428],"about_ca_topic_score_codex":0.00010963721,"about_ca_topic_score_gemma":0.00018443428,"teacher_disagreement_score":0.0011130177,"about_ca_system_score_codex":0.000110639456,"about_ca_system_score_gemma":0.0001334195,"threshold_uncertainty_score":0.0037234426},"labels":[],"label_agreement":null},{"id":"W1973708763","doi":"10.1097/cji.0000000000000022","title":"Targeted siRNA Silencing of Indoleamine 2, 3-Dioxygenase in Antigen-presenting Cells Using Mannose-conjugated Liposomes","year":2014,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University; Cancer Care Ontario","funders":"Canadian Institutes of Health Research","keywords":"Indoleamine 2,3-dioxygenase; Immune system; Cancer research; Spleen; Small interfering RNA; Immunology; FOXP3; Antigen; Gene silencing; Antigen-presenting cell; T cell; Biology; Transfection; Cell culture","score_opus":0.012197924774438476,"score_gpt":0.2486350573814467,"score_spread":0.23643713260700822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973708763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831875,0.0011980175,0.013840802,0.00008381687,0.000045015528,0.00009608524,0.00022148163,0.00012538489,0.0012019806],"genre_scores_gemma":[0.991293,0.00080535334,0.0059764194,0.000042008258,0.000010846198,0.000089737856,0.00020200708,0.000016317763,0.0015642466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999081,0.000011571265,0.000013655531,0.000027202836,0.000020451833,0.000018871357],"domain_scores_gemma":[0.99994695,0.0000104282535,0.000021439117,0.000005500373,0.000006204042,0.000009514493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014120775,0.00033728158,0.00022436501,0.00012100912,0.00009037109,0.00024305574,0.00016568042,0.0002356033,0.00036038915],"category_scores_gemma":[0.000072065515,0.00011897478,0.00024709548,0.000090238565,0.00018523987,0.00017130918,0.00016052178,0.00034174792,0.0001554262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023192431,0.0000071554073,0.000038713282,0.000018421955,0.0000020653613,0.000012337876,0.000006594964,0.000048224923,0.99924767,0.00007755194,0.0000098136,0.0005082259],"study_design_scores_gemma":[0.000010325524,0.00012112024,0.00047128546,0.0000019874678,0.000010953719,0.000040718147,0.000005897935,0.00094069674,0.9975165,0.000016438853,0.0008615361,0.0000025153986],"about_ca_topic_score_codex":0.00041686968,"about_ca_topic_score_gemma":0.00051309523,"teacher_disagreement_score":0.00041686968,"about_ca_system_score_codex":0.00027422843,"about_ca_system_score_gemma":0.00022808179,"threshold_uncertainty_score":0.0019896626},"labels":[],"label_agreement":null},{"id":"W1973747829","doi":"10.1097/cji.0b013e3182941813","title":"Murine Responses to Recombinant MVA Versus ALVAC Vaccines Against Tumor-associated Antigens, gp100 and 5T4","year":2013,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University Health Network","funders":"","keywords":"Immunogenicity; Antigen; Immune system; Virology; Biology; Modified vaccinia Ankara; Vaccination; Immunology; Viral vector; Vector (molecular biology); Immunotherapy; Antibody; Recombinant DNA; Vaccinia","score_opus":0.012952479326827242,"score_gpt":0.25491623072430136,"score_spread":0.2419637513974741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973747829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797624,0.0003497667,0.0007255253,0.00004218167,0.000055272012,0.000039813513,0.00023576168,0.000050218445,0.00052526715],"genre_scores_gemma":[0.9955106,0.00035793407,0.0009826637,0.0001408743,0.00007601302,0.00010456028,0.00088337745,0.000040879826,0.0019030805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991621,0.00016779985,0.00009361173,0.00019934177,0.00012725283,0.00024992737],"domain_scores_gemma":[0.999188,0.00021781579,0.00022942112,0.00008242934,0.00008532197,0.00019706564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006305835,0.0010847852,0.0006431549,0.00067226856,0.00015302638,0.00049955456,0.0003726004,0.0012921355,0.0015872901],"category_scores_gemma":[0.00067057094,0.0003803036,0.00057361415,0.00021428478,0.00043195466,0.00069928385,0.00029036592,0.0025419765,0.00060143886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021957257,0.0006997955,0.0004420986,0.000052887124,0.000025368938,0.00003871198,0.000044536315,0.00032231034,0.99453473,0.000078512865,0.00006255509,0.0015028614],"study_design_scores_gemma":[0.00030221583,0.02542705,0.004855941,0.0000199546,0.00008996889,0.0003145453,0.000058341167,0.0026354305,0.9650607,0.00015082552,0.0010656905,0.000019310231],"about_ca_topic_score_codex":0.0003584445,"about_ca_topic_score_gemma":0.00018983014,"teacher_disagreement_score":0.0015872901,"about_ca_system_score_codex":0.0005135633,"about_ca_system_score_gemma":0.00022108035,"threshold_uncertainty_score":0.0053100586},"labels":[],"label_agreement":null},{"id":"W1990951986","doi":"10.1097/cji.0000000000000055","title":"Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC)","year":2014,"lang":"fr","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Amgen","keywords":"Renal cell carcinoma; Medicine; Adjuvant; Interleukin 2; Interferon; Cancer research; Oncology; Internal medicine; Cytokine; Immunology","score_opus":0.011849089476180793,"score_gpt":0.25664498185556045,"score_spread":0.24479589237937965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990951986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185103,0.0070123696,0.0003739688,0.00013895652,0.000083048035,0.0002453085,0.000053029526,0.000011997498,0.00023032562],"genre_scores_gemma":[0.9955332,0.0027874934,0.0006573962,0.00017771668,0.00010558999,0.0003345448,0.00009533776,0.00000237229,0.00030619284],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99972767,0.00016098931,0.000021896247,0.000029089788,0.000029284798,0.00003096276],"domain_scores_gemma":[0.9996941,0.00011607429,0.000093290015,0.00001912208,0.0000131699035,0.00006418055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010408985,0.0002647129,0.00088312203,0.0001619973,0.00011713147,0.00027998746,0.00031380638,0.0003495469,0.00072712376],"category_scores_gemma":[0.00065284735,0.0001340768,0.00039262674,0.000172307,0.0003379538,0.0002516089,0.00018005134,0.0009628481,0.00013079474],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59872246,0.025613096,0.013257254,0.0022274603,0.0006367512,0.0001868968,0.00012944952,0.0027370655,0.034736533,0.0003018579,0.0009745314,0.32047668],"study_design_scores_gemma":[0.21086565,0.7441417,0.024255631,0.0002622575,0.0012012603,0.00037785873,0.00009490668,0.0033220756,0.011172061,0.0004663083,0.0038131198,0.000027050983],"about_ca_topic_score_codex":0.0002355514,"about_ca_topic_score_gemma":0.0008065431,"teacher_disagreement_score":0.0010408985,"about_ca_system_score_codex":0.00035861525,"about_ca_system_score_gemma":0.0006201072,"threshold_uncertainty_score":0.005504906},"labels":[],"label_agreement":null},{"id":"W1991536229","doi":"10.1097/01.cji.0000210081.60178.b4","title":"Dendritic Cells Matured With TNF can be Further Activated In Vitro and After Subcutaneous Injection In Vivo Which Converts Their Tolerogenicity Into Immunogenicity","year":2006,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian MPS Society for Mucopolysaccharide and Related Diseases","funders":"","keywords":"Immunogenicity; In vivo; In vitro; Subcutaneous injection; Tumor necrosis factor alpha; Chemistry; Cell biology; Immunology; Medicine; Biology; Internal medicine; Biotechnology; Immune system; Biochemistry","score_opus":0.0038232249605540626,"score_gpt":0.19878301707523083,"score_spread":0.19495979211467676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991536229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746012,0.0043085543,0.012515038,0.00021383484,0.00021378306,0.00013019408,0.00039814835,0.00030305606,0.007316214],"genre_scores_gemma":[0.99066985,0.0014222141,0.0032927461,0.00010411061,0.00006581633,0.000055243865,0.0003711097,0.000026222559,0.003992747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998258,0.00003963363,0.000012642687,0.00002455071,0.00004400863,0.00005339741],"domain_scores_gemma":[0.9998599,0.000025408273,0.000035620065,0.00003141245,0.000013525876,0.00003410915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016538874,0.00037778934,0.0002594747,0.00014999908,0.00009209817,0.00030907532,0.00008256595,0.00021958523,0.0016769057],"category_scores_gemma":[0.00015092935,0.00008069685,0.00019234593,0.00013436376,0.00016779812,0.0001460421,0.00016275968,0.00055508537,0.0008332037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010987089,0.000046839054,0.00018111902,0.000031047453,0.0000023877108,0.000058122,0.000008092928,0.00003215421,0.9960062,0.00014679471,0.000059746653,0.0033177237],"study_design_scores_gemma":[0.00003870834,0.00072027143,0.0019740406,0.000009966185,0.000012352417,0.00052702037,0.000015086237,0.00032689847,0.9911142,0.00013259637,0.005125609,0.0000031033856],"about_ca_topic_score_codex":0.000064120264,"about_ca_topic_score_gemma":0.000105496045,"teacher_disagreement_score":0.0016769057,"about_ca_system_score_codex":0.00013179719,"about_ca_system_score_gemma":0.000135958,"threshold_uncertainty_score":0.00560987},"labels":[],"label_agreement":null},{"id":"W1995183264","doi":"10.1097/01.cji.0000175693.08608.a8","title":"LF 15-0195 Generates Synergistic Tolerance by Promoting Formation of CD4+CD25+CTLA4+ T Cells","year":2005,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Chemistry; Cell biology; Biology","score_opus":0.007262054139875491,"score_gpt":0.22939263831298465,"score_spread":0.22213058417310916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995183264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970091,0.0008037329,0.00092195417,0.00003862177,0.000018225912,0.000017622604,0.000056568577,0.000042529875,0.0010918322],"genre_scores_gemma":[0.9978648,0.00036644135,0.00072663,0.000038953556,0.00001609245,0.000017606537,0.00013482502,0.000008059538,0.000826581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998117,0.000055317927,0.000014684123,0.000020089736,0.000045871413,0.000052412837],"domain_scores_gemma":[0.9998776,0.00003052241,0.000025964035,0.000020301926,0.0000065771997,0.000039100498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015786152,0.0003187511,0.00028686255,0.00024910874,0.00009510134,0.00029046892,0.00015302727,0.00020350011,0.001167613],"category_scores_gemma":[0.00014559744,0.000106521366,0.00019927525,0.00010833554,0.00018257192,0.000156013,0.00021813285,0.00050504215,0.00030202343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028961367,0.000097733486,0.00022114684,0.000038056533,0.00000667726,0.00007072599,0.000011281397,0.00013365094,0.99518186,0.00008269077,0.00003430974,0.003832379],"study_design_scores_gemma":[0.00008765116,0.0020474698,0.0027420407,0.000009640888,0.000036765112,0.00041268126,0.000025763446,0.0007236978,0.9914057,0.000077301214,0.0024262746,0.000004952373],"about_ca_topic_score_codex":0.0001239219,"about_ca_topic_score_gemma":0.00022546406,"teacher_disagreement_score":0.001167613,"about_ca_system_score_codex":0.00015361073,"about_ca_system_score_gemma":0.00017044417,"threshold_uncertainty_score":0.0039060712},"labels":[],"label_agreement":null},{"id":"W2000145027","doi":"10.1097/cji.0b013e31823735d6","title":"Ipilimumab in Treatment-naive and Previously Treated Patients with Metastatic Melanoma","year":2011,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital","funders":"National Comprehensive Cancer Network; Bristol-Myers Squibb","keywords":"Ipilimumab; Medicine; Internal medicine; Placebo; Clinical endpoint; Diarrhea; Gastroenterology; Clinical trial; Oncology; Surgery; Cancer; Immunotherapy; Pathology","score_opus":0.020619749534033782,"score_gpt":0.2517715644603501,"score_spread":0.2311518149263163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000145027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965191,0.0025545417,0.00008171695,0.000087888824,0.000017499486,0.000061025403,0.0002137525,0.0000044179683,0.00046009803],"genre_scores_gemma":[0.99884915,0.0004828269,0.000078959485,0.00014904096,0.00003112984,0.000040368537,0.00025373112,0.0000010546004,0.00011382892],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99937207,0.0002584743,0.00006811082,0.00014034682,0.00008659547,0.00007438184],"domain_scores_gemma":[0.99910504,0.0002868962,0.0003142164,0.00004439784,0.000033744123,0.00021573009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008810326,0.00021544925,0.00065919984,0.00041992942,0.00038293935,0.00042614978,0.00021243985,0.00052111124,0.0009588548],"category_scores_gemma":[0.0017748786,0.0002530806,0.0006066484,0.0004962968,0.0003153569,0.00037681512,0.00020174647,0.00058748695,0.00016465124],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022055984,0.00080698053,0.95075905,0.00018008333,0.00044547342,0.00074722234,0.00015761046,0.00027166968,0.0044133593,0.000080169804,0.00045158115,0.01963078],"study_design_scores_gemma":[0.0026117447,0.01409196,0.9781812,0.000040435483,0.00042658337,0.0015229917,0.00013575259,0.0006823742,0.0007734068,0.00012804678,0.0013874059,0.000018119083],"about_ca_topic_score_codex":0.0012940401,"about_ca_topic_score_gemma":0.0023768672,"teacher_disagreement_score":0.0012940401,"about_ca_system_score_codex":0.0005564388,"about_ca_system_score_gemma":0.0005094208,"threshold_uncertainty_score":0.0046594143},"labels":[],"label_agreement":null},{"id":"W2004345869","doi":"10.1097/01.cji.0000210386.55951.c2","title":"IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells","year":2006,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":441,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute","keywords":"CD8; Cytokine; Immunology; Immunotherapy; In vivo; Interleukin 2; Human immunodeficiency virus (HIV); Medicine; T lymphocyte; Cancer research; Pharmacology; Biology; Immune system; Biotechnology","score_opus":0.00880907357123193,"score_gpt":0.2424195119768947,"score_spread":0.23361043840566278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004345869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428978,0.026072266,0.016196946,0.0013613121,0.00066892547,0.00024595653,0.00059790496,0.0008669526,0.0110920835],"genre_scores_gemma":[0.9824609,0.005589651,0.006752592,0.0005614769,0.00028679104,0.0001633109,0.0006818559,0.00007612748,0.0034272436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997633,0.0000948627,0.000011976072,0.000042813423,0.000055305383,0.00003181314],"domain_scores_gemma":[0.99983025,0.000049597238,0.00004091435,0.000028366796,0.000015576337,0.00003532295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028455295,0.0005133457,0.00028149356,0.00028466148,0.00014719705,0.00033918518,0.00013075571,0.00033643554,0.0021014381],"category_scores_gemma":[0.00027053436,0.00014212824,0.00016399863,0.000081578735,0.00048526682,0.00017789195,0.00014065583,0.00084954506,0.00076639216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024999604,0.00090866163,0.0026497648,0.00027061347,0.00006104423,0.00050495577,0.00007250316,0.00023026933,0.92987305,0.00063606276,0.0017270778,0.060565904],"study_design_scores_gemma":[0.0007369512,0.028529555,0.007004666,0.00012810627,0.00022816188,0.004658426,0.00012608951,0.0014584344,0.91289794,0.0009288515,0.04327877,0.00002394339],"about_ca_topic_score_codex":0.00006814944,"about_ca_topic_score_gemma":0.00010391473,"teacher_disagreement_score":0.0021014381,"about_ca_system_score_codex":0.00012310101,"about_ca_system_score_gemma":0.00021292105,"threshold_uncertainty_score":0.00703007},"labels":[],"label_agreement":null},{"id":"W2005889192","doi":"10.1097/cji.0b013e3181cd872d","title":"IL-7 Enhances Survival of Human CD56bright NK Cells","year":2010,"lang":"fr","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Stimulation; Cell biology; Lymphokine-activated killer cell; Interleukin 21; Interleukin 12; Cytokine; Interleukin 15; Janus kinase 3; Biology; Immunology; Cell; Cancer research; Interleukin; Immune system; T cell; In vitro; Cytotoxic T cell; Neuroscience","score_opus":0.01038586555752329,"score_gpt":0.26277201569734426,"score_spread":0.25238615013982096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005889192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456054,0.0030502672,0.0005688504,0.00006774574,0.000034086243,0.000017411643,0.00017084669,0.000033791097,0.0014964474],"genre_scores_gemma":[0.99535453,0.0012716979,0.0005945718,0.00005537488,0.0000250829,0.000018203804,0.0006099387,0.000014099715,0.0020566995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986744,0.000030720268,0.00001191207,0.00001579204,0.000036341007,0.000037805825],"domain_scores_gemma":[0.9999064,0.000033006632,0.000011776556,0.000016437556,0.0000148912495,0.000017394532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001065036,0.00017754949,0.00020210844,0.00011667633,0.00006987177,0.00026574844,0.000074738244,0.000092814415,0.0020991226],"category_scores_gemma":[0.00017656002,0.00004757228,0.0001324099,0.00007721315,0.00008876295,0.00012364899,0.00019940146,0.00028010306,0.00065674825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012676567,0.0001800477,0.0013261011,0.00011865579,0.000015590398,0.000114108516,0.000087198,0.00021812486,0.9764206,0.00012221563,0.00044376522,0.019685922],"study_design_scores_gemma":[0.00014468403,0.0029339746,0.014702955,0.000027733166,0.000062010055,0.00071732304,0.00009106763,0.0013179682,0.96699834,0.00010945033,0.012887052,0.0000075256144],"about_ca_topic_score_codex":0.00024585985,"about_ca_topic_score_gemma":0.0004351234,"teacher_disagreement_score":0.0020991226,"about_ca_system_score_codex":0.00011625176,"about_ca_system_score_gemma":0.00018256999,"threshold_uncertainty_score":0.0070222616},"labels":[],"label_agreement":null},{"id":"W2008591960","doi":"10.1097/00002371-200501000-00004","title":"Effect of Serum and Antioxidants on the Immunogenicity of Protein Kinase C-Activated Chronic Lymphocytic Leukemia Cells","year":2004,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Immunogenicity; Chronic lymphocytic leukemia; Immune system; Protein kinase C; Immunology; Chemistry; Cancer research; Cell biology; Leukemia; Biology; Signal transduction","score_opus":0.008655550279923095,"score_gpt":0.2739041142319836,"score_spread":0.2652485639520605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008591960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274784,0.004685356,0.00039533596,0.000096593496,0.00006410908,0.00002198137,0.00016621986,0.00004168062,0.0017808342],"genre_scores_gemma":[0.99658597,0.0014052645,0.0005351095,0.0000818189,0.00002531409,0.000021883565,0.00028943652,0.000008487224,0.0010468011],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986756,0.000041790445,0.000014840174,0.000013328983,0.00002431416,0.000038047623],"domain_scores_gemma":[0.9998418,0.000047264,0.000026074766,0.000018928631,0.000028443028,0.000037376107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019889332,0.0003289488,0.00035358235,0.00018507887,0.00013870014,0.00027006946,0.00013570065,0.00021001381,0.0009105426],"category_scores_gemma":[0.0002059754,0.00006319876,0.00022303879,0.00014867919,0.00012660043,0.0001490869,0.00018350546,0.0002927707,0.00018802767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036955199,0.00045937262,0.00084980496,0.00026015268,0.00003936148,0.00014717353,0.0000911619,0.00021379991,0.98115796,0.00019341867,0.0002717771,0.0126203345],"study_design_scores_gemma":[0.00024173154,0.0036892346,0.0054011256,0.000027302927,0.000068229034,0.00029346583,0.000056183762,0.00084198004,0.9843009,0.000071896386,0.0049994807,0.000008586177],"about_ca_topic_score_codex":0.0007265357,"about_ca_topic_score_gemma":0.0009182894,"teacher_disagreement_score":0.0009105426,"about_ca_system_score_codex":0.0001715012,"about_ca_system_score_gemma":0.00025137077,"threshold_uncertainty_score":0.0030460954},"labels":[],"label_agreement":null},{"id":"W2015821984","doi":"10.1097/00002371-200007000-00009","title":"Induction of Tumor-Specific Immunity in Mice by Immunization With Reconstituted Tumor Membrane Liposomes Containing Recombinant B7-2 (CD86)","year":2000,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Sept Iles","funders":"National Cancer Institute","keywords":"Immunogenicity; CD86; Immunization; Recombinant DNA; Liposome; Fibrosarcoma; Cancer research; Immunology; Biology; Immune system; Chemistry; Medicine; T cell; Gene; Biochemistry; Pathology","score_opus":0.010235376897674696,"score_gpt":0.22401098642193393,"score_spread":0.21377560952425922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015821984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97831774,0.001968843,0.010935639,0.00086537394,0.00025766977,0.00059116463,0.00086561,0.0013775289,0.0048204307],"genre_scores_gemma":[0.9798052,0.0019136553,0.009787492,0.0004361033,0.00014241348,0.00048863614,0.0014130062,0.00013763465,0.0058759744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994843,0.00008585546,0.000057471894,0.000111422916,0.000093628514,0.00016726798],"domain_scores_gemma":[0.99943215,0.00011728496,0.00016524333,0.000097053846,0.000050484494,0.0001376739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008725571,0.0012934863,0.0007252946,0.0015132864,0.0003348492,0.0006298117,0.0005564847,0.00152749,0.0018552957],"category_scores_gemma":[0.0003848642,0.00057693745,0.0006138787,0.00030457697,0.00071374705,0.0006743405,0.00044265098,0.002951538,0.00096039544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008255222,0.0013420086,0.00020132883,0.000116290386,0.00002537443,0.000067628825,0.00005609595,0.0003130324,0.9927078,0.00057688664,0.00020368221,0.0035644262],"study_design_scores_gemma":[0.0005607266,0.006065972,0.0012674768,0.000033637934,0.000049513506,0.00026314348,0.000025830706,0.0024184764,0.9857142,0.00038390112,0.0032032852,0.000013888504],"about_ca_topic_score_codex":0.00036838275,"about_ca_topic_score_gemma":0.0002991699,"teacher_disagreement_score":0.0018552957,"about_ca_system_score_codex":0.0005135703,"about_ca_system_score_gemma":0.00046113663,"threshold_uncertainty_score":0.006206572},"labels":[],"label_agreement":null},{"id":"W2020793885","doi":"10.1097/00002371-200201000-00008","title":"CD20-Directed Serotherapy in Patients With Multiple Myeloma: Biologic Considerations and Therapeutic Applications","year":2002,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"CD20; Rituximab; Medicine; Multiple myeloma; Lymphoma; Immunology; Bone marrow; Chronic lymphocytic leukemia; Monoclonal; Chemoimmunotherapy; Internal medicine; Leukemia; Monoclonal antibody; Antibody","score_opus":0.024551432524570784,"score_gpt":0.2738442964361995,"score_spread":0.24929286391162872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020793885","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7612885,0.2232943,0.0019080652,0.0051898677,0.00015359116,0.0000799891,0.000047403002,0.000049327624,0.007988966],"genre_scores_gemma":[0.9742288,0.022541087,0.001144453,0.00088071526,0.00036647456,0.000030221092,0.000034422057,0.0000027491787,0.00077087013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999151,0.0000411686,0.000008173198,0.000009301757,0.000015444117,0.000010687792],"domain_scores_gemma":[0.9998623,0.00006375945,0.000030830906,0.000004906651,0.0000128105785,0.000025358999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038154208,0.00018586051,0.00022884789,0.00019386754,0.00013042957,0.00025186833,0.000118956305,0.00028349712,0.0008424942],"category_scores_gemma":[0.00046540092,0.000059067163,0.00013141907,0.00014623009,0.00014412183,0.00015637581,0.000101196114,0.00034577298,0.00011761151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033187943,0.00065454043,0.048659723,0.0006446948,0.00010860265,0.0017837232,0.00026058583,0.0006508173,0.03623078,0.000999345,0.0028977103,0.90379065],"study_design_scores_gemma":[0.006731343,0.07450735,0.6274892,0.0011342363,0.0012460315,0.03567932,0.0007376039,0.007944735,0.062388476,0.002790676,0.17926766,0.000083315],"about_ca_topic_score_codex":0.00041125604,"about_ca_topic_score_gemma":0.0010053992,"teacher_disagreement_score":0.0008424942,"about_ca_system_score_codex":0.00031133866,"about_ca_system_score_gemma":0.00019409023,"threshold_uncertainty_score":0.0028184056},"labels":[],"label_agreement":null},{"id":"W2021274125","doi":"10.1097/cji.0b013e3181c1f1e9","title":"A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses","year":2010,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Immunovaccine (Canada)","funders":"","keywords":"Adjuvant; Ovarian cancer; Immune system; Medicine; Peptide vaccine; Immunology; Lymph node; Cancer vaccine; Epitope; CD8; Antigen; FOXP3; Cancer; Immunotherapy; Internal medicine","score_opus":0.026861168625879853,"score_gpt":0.2738996614744544,"score_spread":0.24703849284857454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021274125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994989,0.00064458116,0.0031387266,0.00006842391,0.00003182499,0.00008113709,0.00012714141,0.000066375746,0.00085279037],"genre_scores_gemma":[0.9906529,0.0005778468,0.007016628,0.00008667168,0.000019839601,0.000061960716,0.00032246904,0.000020681966,0.0012409866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999145,0.000009808786,0.000005933204,0.000021438094,0.000021191667,0.000027059796],"domain_scores_gemma":[0.9999472,0.0000074924747,0.000019145884,0.0000049671467,0.0000055309993,0.000015714064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011380234,0.0003307989,0.00021727993,0.00015985475,0.000067928966,0.00024434694,0.00016595221,0.00033103424,0.0007141972],"category_scores_gemma":[0.0000756253,0.00012896629,0.00018241009,0.0000867957,0.00013468778,0.00027444394,0.00020723793,0.00052688597,0.000251159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005630556,0.00006078852,0.000081706574,0.000031063555,0.0000025007241,0.000030474297,0.00000557785,0.00013773168,0.99746394,0.000051083145,0.000024125966,0.002054632],"study_design_scores_gemma":[0.000093448994,0.0031505877,0.0019963037,0.000007974381,0.000026315298,0.0005340628,0.0000137344405,0.0014491376,0.9894894,0.000057913887,0.0031747334,0.0000064455576],"about_ca_topic_score_codex":0.00010304158,"about_ca_topic_score_gemma":0.00019720326,"teacher_disagreement_score":0.0007141972,"about_ca_system_score_codex":0.0001252036,"about_ca_system_score_gemma":0.00018184762,"threshold_uncertainty_score":0.0023891926},"labels":[],"label_agreement":null},{"id":"W2041021823","doi":"10.1097/cji.0b013e318207ecdf","title":"The Human Cathelicidin, LL-37, Induces Granzyme-mediated Apoptosis in Regulatory T Cells","year":2011,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Granzyme; Granzyme A; Granzyme B; Apoptosis; Cytotoxic T cell; Cathelicidin; IL-2 receptor; FOXP3; Programmed cell death; Biology; DNA fragmentation; Molecular biology; Caspase; Perforin; Immune system; Cell biology; Chemistry; T cell; Immunology; CD8; Innate immune system; Biochemistry; In vitro","score_opus":0.018572491192891914,"score_gpt":0.23052064366653102,"score_spread":0.2119481524736391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041021823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950913,0.0022184427,0.0016994488,0.00006269763,0.000033740198,0.00003215312,0.000113657705,0.000058054335,0.00069058454],"genre_scores_gemma":[0.99742943,0.00073965284,0.00094466406,0.00007754271,0.0000164718,0.000031672324,0.00017611239,0.000010052842,0.0005743127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997081,0.00007741634,0.000034227523,0.000039015093,0.00005967491,0.00008146596],"domain_scores_gemma":[0.9998369,0.000045033044,0.000037871898,0.00002702149,0.000020697971,0.000032390988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025486544,0.0004185989,0.00035030546,0.00022005218,0.00012700536,0.00030044588,0.00015100608,0.00030271558,0.0006055428],"category_scores_gemma":[0.00027586028,0.00011878547,0.00040514293,0.0001304557,0.00022907603,0.00018116055,0.00020700943,0.0006505486,0.0002598312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037755904,0.000047038982,0.0004295795,0.00005396045,0.0000075819244,0.00015776257,0.000026489093,0.00008563319,0.9966354,0.0000350207,0.000030651583,0.0021133313],"study_design_scores_gemma":[0.00007898973,0.0012772367,0.0039396626,0.000014729644,0.000035748842,0.0008277303,0.00005204294,0.0008634451,0.99118716,0.00011470677,0.0016031119,0.000005302727],"about_ca_topic_score_codex":0.00028311278,"about_ca_topic_score_gemma":0.0003014087,"teacher_disagreement_score":0.0006055428,"about_ca_system_score_codex":0.00024354403,"about_ca_system_score_gemma":0.0002385656,"threshold_uncertainty_score":0.002025783},"labels":[],"label_agreement":null},{"id":"W2042901152","doi":"10.1097/cji.0b013e318197b2a0","title":"Semiquantitation of Mouse Dendritic Cell Migration In Vivo Using Cellular MRI","year":2009,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; In vivo; Magnetic resonance imaging; Cancer research; Dendritic cell; Immune system; Adjuvant; Breast cancer; Pathology; Cancer; Immunology; Internal medicine; Biology; Radiology","score_opus":0.012507857667938108,"score_gpt":0.2560128178451338,"score_spread":0.2435049601771957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042901152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86444414,0.0022476253,0.1274084,0.00024175773,0.00007846801,0.0002079476,0.00040672833,0.00064718147,0.004317853],"genre_scores_gemma":[0.8858616,0.0028088016,0.103903115,0.00012460712,0.000054260487,0.00037283372,0.0005882999,0.00020443332,0.0060819685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997974,0.000045538924,0.0000136947465,0.000060327897,0.000043499156,0.00003953066],"domain_scores_gemma":[0.9997569,0.00007802347,0.00005889228,0.000035667075,0.00004006908,0.00003047754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044210846,0.00062418735,0.00017956049,0.0005677216,0.00021130352,0.00035211755,0.00032361876,0.00040119217,0.0007157353],"category_scores_gemma":[0.00022902232,0.00020332399,0.00015390584,0.0002359229,0.00038871664,0.0002991799,0.00025893844,0.0007832779,0.00040227443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027561447,0.000010043647,0.000036025802,0.00001508606,0.0000010173028,0.000009693569,0.000014996793,0.000048816546,0.9990044,0.00010614212,0.000010505665,0.0007156484],"study_design_scores_gemma":[0.000009808665,0.00011397456,0.00056650676,0.000004324079,0.0000061990268,0.00005484489,0.000014200056,0.0022954424,0.9959336,0.00006259524,0.0009348856,0.0000036461042],"about_ca_topic_score_codex":0.0008046707,"about_ca_topic_score_gemma":0.0010667467,"teacher_disagreement_score":0.0008046707,"about_ca_system_score_codex":0.0003702948,"about_ca_system_score_gemma":0.00027484144,"threshold_uncertainty_score":0.0026866794},"labels":[],"label_agreement":null},{"id":"W2054621145","doi":"10.1097/01.cji.0000191021.90544.75","title":"The Role of the Ovarian Tumor Marker CA125 (MUC16) in the Suppression of Human Immune Responses","year":2005,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Innate immune system; Immune system; Immunity; Ovarian cancer; Immunology; Tumor immunology; Medicine; Biology; Immunotherapy; Cancer; Internal medicine","score_opus":0.013656639850133406,"score_gpt":0.3192505343208218,"score_spread":0.3055938944706884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054621145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475486,0.044257335,0.0012424296,0.00064429117,0.00011862363,0.000049911203,0.00020119837,0.00004326826,0.005894411],"genre_scores_gemma":[0.9951208,0.0030625155,0.00029825716,0.000059140275,0.00004170931,0.000011454287,0.000062155705,0.0000034787056,0.0013403997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992263,0.000024863748,0.000005935052,0.000009475878,0.000015317644,0.000021741653],"domain_scores_gemma":[0.99990904,0.000024688965,0.000024751533,0.000009975006,0.000008069921,0.000023401875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002647278,0.00021770273,0.00021457714,0.00028389177,0.0001254754,0.00049681886,0.00014218665,0.00022641581,0.001347837],"category_scores_gemma":[0.0004884399,0.000108600536,0.00016140383,0.00011526604,0.00022785878,0.00022542407,0.00017648614,0.0003227911,0.00017643615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00620014,0.00029800533,0.020326903,0.00037914506,0.00007861528,0.00078310474,0.00013965591,0.00087732676,0.7902165,0.0026535632,0.0017623965,0.1762846],"study_design_scores_gemma":[0.00050862716,0.00532344,0.25559404,0.0001481697,0.00022285416,0.0042356947,0.00027869127,0.0055041993,0.68194324,0.002483985,0.04371699,0.000040073544],"about_ca_topic_score_codex":0.0009947096,"about_ca_topic_score_gemma":0.0007118495,"teacher_disagreement_score":0.001347837,"about_ca_system_score_codex":0.0003291621,"about_ca_system_score_gemma":0.00032621488,"threshold_uncertainty_score":0.004508972},"labels":[],"label_agreement":null},{"id":"W2056969658","doi":"10.1097/cji.0b013e31802cf3e3","title":"“Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells","year":2007,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immune system; PLGA; Antigen; Adjuvant; Dendritic cell; Proinflammatory cytokine; Antigen-presenting cell; T cell; Chemistry; Immunology; Biology; In vitro; Inflammation; Biochemistry","score_opus":0.011860697973561313,"score_gpt":0.2622933895295807,"score_spread":0.2504326915560194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056969658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7878212,0.020570423,0.18291688,0.0009864547,0.00039934495,0.0006086323,0.0004100049,0.0006379324,0.005649079],"genre_scores_gemma":[0.90283495,0.0063404283,0.08626293,0.0003581411,0.000064887754,0.00021582458,0.00035636366,0.00005025277,0.0035162107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985325,0.000042238204,0.000011843901,0.000035004345,0.000038640224,0.000019067249],"domain_scores_gemma":[0.9999504,0.000009948722,0.0000139064605,0.0000062472695,0.000012715377,0.0000066729904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002402213,0.0003331425,0.00024309514,0.00014666773,0.00013771937,0.0003086663,0.00021238698,0.00043797374,0.00041036945],"category_scores_gemma":[0.00020087561,0.00013627562,0.00027217565,0.00008339792,0.00013858471,0.00025935896,0.00017358022,0.00037967673,0.00041570433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033830398,0.000021996528,0.00005779164,0.00009434618,0.0000041559174,0.000042702668,0.000009808153,0.00030445066,0.9936162,0.0004019805,0.0000788282,0.005333834],"study_design_scores_gemma":[0.000011856608,0.00024975976,0.00022651837,0.000012905637,0.000016239512,0.000269858,0.00000909736,0.0028908206,0.9876435,0.00014733773,0.008515991,0.000006152629],"about_ca_topic_score_codex":0.00020405871,"about_ca_topic_score_gemma":0.00024009286,"teacher_disagreement_score":0.00043797374,"about_ca_system_score_codex":0.00032541502,"about_ca_system_score_gemma":0.00024468848,"threshold_uncertainty_score":0.0023610592},"labels":[],"label_agreement":null},{"id":"W2059063810","doi":"10.1097/cji.0b013e31820d2a21","title":"Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells","year":2011,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; National Institutes of Health; Johns Hopkins University","keywords":"Lymphokine-activated killer cell; Interleukin 12; Cytotoxicity; NK-92; NKG2D; Janus kinase 3; Interleukin 21; Natural killer cell; Biology; Cytotoxic T cell; Immunotherapy; Tumor necrosis factor alpha; Immunology; Cytolysis; Cell biology; Cancer research; Chemistry; Antigen; Immune system; In vitro; Biochemistry; CD8","score_opus":0.01593651748391285,"score_gpt":0.23729041762105,"score_spread":0.22135390013713713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059063810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992434,0.0018335461,0.0031702006,0.000077480785,0.0000303455,0.000048909085,0.00027099013,0.000083097635,0.0020515022],"genre_scores_gemma":[0.99642295,0.0003463109,0.001305564,0.000063962914,0.000010179458,0.000031537005,0.0003641273,0.00001708301,0.0014381813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996106,0.000039347793,0.00004985824,0.000060505477,0.00011394568,0.00012588772],"domain_scores_gemma":[0.9998596,0.000013809096,0.000043007723,0.000018800674,0.000017939112,0.00004678874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017461326,0.0003939502,0.00030631668,0.00017049146,0.00010096593,0.0006066941,0.000267824,0.00025488393,0.001468498],"category_scores_gemma":[0.00020289408,0.00012758253,0.00028252657,0.000118865704,0.00021775237,0.0003942756,0.00037383678,0.0007715619,0.00057133636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021033594,0.000024105717,0.00064558646,0.0000532931,0.000005265843,0.000079402475,0.00002770976,0.00015317903,0.996298,0.00026937883,0.000031691445,0.0022021062],"study_design_scores_gemma":[0.000083954816,0.000408729,0.0062330277,0.00001865215,0.000039388815,0.0005960696,0.00008172994,0.0017110285,0.9863819,0.00022155566,0.004215439,0.00000854554],"about_ca_topic_score_codex":0.000468707,"about_ca_topic_score_gemma":0.0005449506,"teacher_disagreement_score":0.001468498,"about_ca_system_score_codex":0.000562408,"about_ca_system_score_gemma":0.00039527286,"threshold_uncertainty_score":0.0049126744},"labels":[],"label_agreement":null},{"id":"W2073651499","doi":"10.1097/cji.0b013e3181a6981c","title":"Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin","year":2009,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Immunotoxin; Epitope; Epithelial cell adhesion molecule; In vitro; Linker; Chemistry; Molecular biology; Fusion protein; Furin; Moiety; Recombinant DNA; In vivo; Biology; Cell; Biochemistry; Antigen; Gene; Cytotoxicity; Stereochemistry; Immunology; Genetics","score_opus":0.010394736040329706,"score_gpt":0.20453073554271795,"score_spread":0.19413599950238825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073651499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943674,0.0004144497,0.0043229545,0.000042571835,0.0000078881885,0.000039255345,0.00020657066,0.000016227274,0.00058246765],"genre_scores_gemma":[0.9910597,0.0003375316,0.0058814567,0.000037775633,0.0000036741014,0.00002075073,0.0009678298,0.000013267299,0.0016780079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989665,0.000014671386,0.000008710043,0.000020027395,0.00003908804,0.000020886338],"domain_scores_gemma":[0.9999255,0.000009456387,0.000025723197,0.0000069707344,0.000013102239,0.000019183026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016267403,0.00020636796,0.00015244282,0.00016922719,0.00012160935,0.0002477846,0.00019810014,0.0002547282,0.00030060834],"category_scores_gemma":[0.00014238256,0.000091983275,0.00017292076,0.00015717647,0.00017049049,0.00014184864,0.00013804002,0.00037553237,0.00018006715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000123750115,0.00001008227,0.0000653362,0.000009387112,0.0000011056561,0.000018233091,0.00000614678,0.000113757036,0.99943095,0.00003729869,0.000005592529,0.00028970523],"study_design_scores_gemma":[0.00000867746,0.000296146,0.0028094014,0.000004177212,0.000009579979,0.00021250699,0.000016808464,0.0010861608,0.99337846,0.000017493814,0.0021572446,0.0000034023935],"about_ca_topic_score_codex":0.001365558,"about_ca_topic_score_gemma":0.0010372759,"teacher_disagreement_score":0.001365558,"about_ca_system_score_codex":0.0004304785,"about_ca_system_score_gemma":0.00015050598,"threshold_uncertainty_score":0.003123343},"labels":[],"label_agreement":null},{"id":"W2077633929","doi":"10.1097/cji.0b013e318243f213","title":"Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer","year":2012,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute","keywords":"Ovarian cancer; Cytotoxic T cell; Immunotherapy; Medicine; Cancer immunotherapy; Immunology; Lymphocyte; Cancer; Cancer research; Immune system; Internal medicine; Biology","score_opus":0.03650980964972917,"score_gpt":0.3572020405419712,"score_spread":0.320692230892242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077633929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946997,0.003991368,0.00042747095,0.00007445459,0.000014704049,0.00004884467,0.000009366084,0.000016652815,0.0007173409],"genre_scores_gemma":[0.99824715,0.0008195486,0.00039000085,0.00005026643,0.000035412988,0.0000321252,0.000036887584,0.0000027398448,0.0003859124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999879,0.000063113665,0.0000038290136,0.000013644316,0.000016922717,0.000023485705],"domain_scores_gemma":[0.999943,0.00001835044,0.000008772955,0.000007575494,0.000006913714,0.000015373598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033442013,0.00019740494,0.0003125145,0.000114860835,0.00018113342,0.00018971488,0.000083017294,0.00024847707,0.00086378644],"category_scores_gemma":[0.00027965772,0.0000620363,0.00013323376,0.00008587273,0.00018122101,0.000119777076,0.000096582255,0.0002714275,0.00019093456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011166101,0.0043482357,0.04229322,0.0003619791,0.000074426476,0.0009684273,0.00034243555,0.0010018238,0.6297541,0.00041781552,0.0009780689,0.30829346],"study_design_scores_gemma":[0.008570681,0.38964203,0.22733149,0.00016579211,0.00062006334,0.013871748,0.0003683359,0.008468007,0.31444347,0.0016698166,0.034787457,0.00006105273],"about_ca_topic_score_codex":0.00018332864,"about_ca_topic_score_gemma":0.00027034612,"teacher_disagreement_score":0.00086378644,"about_ca_system_score_codex":0.00017944514,"about_ca_system_score_gemma":0.00025109484,"threshold_uncertainty_score":0.0028896928},"labels":[],"label_agreement":null},{"id":"W2078126933","doi":"10.1097/cji.0000000000000031","title":"T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells","year":2014,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Division of Chemistry; Laboratorio de Inmunología y Virología, Universidad Autónoma de Nuevo León; Northeast Agricultural University; Institut National de la Santé et de la Recherche Médicale","keywords":"CTL*; Cytotoxic T cell; Human leukocyte antigen; Medicine; Immunology; Virus; Lymphoma; Toxicity; Population; Immunotherapy; Virology; Antigen; Internal medicine; Immune system; Biology; CD8; In vitro","score_opus":0.018611759531367258,"score_gpt":0.26409209350927226,"score_spread":0.245480333977905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078126933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92206836,0.009256825,0.06152789,0.00038408372,0.0003742605,0.0008784208,0.0006444042,0.00050974666,0.0043560155],"genre_scores_gemma":[0.95633805,0.004207851,0.032147247,0.00038843026,0.00018607694,0.000996911,0.0023243732,0.00008075298,0.003330346],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992267,0.00025826273,0.000097968106,0.0001567595,0.00020570758,0.000054704815],"domain_scores_gemma":[0.99951947,0.0001861269,0.000053045405,0.00014578177,0.000049052334,0.000046497742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001253557,0.0005750308,0.000975679,0.00041310638,0.0003571424,0.00086908625,0.0006200475,0.0005141907,0.0021871638],"category_scores_gemma":[0.0011000182,0.00022145039,0.00042538572,0.00035355386,0.00025557622,0.00049320713,0.00066521746,0.001123313,0.0008995038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032779563,0.0025939883,0.0057123364,0.0006214277,0.00033706272,0.0006937739,0.00022592145,0.004602969,0.8410457,0.0014834637,0.0017281178,0.1376773],"study_design_scores_gemma":[0.0012803858,0.010986571,0.0055703707,0.00010698324,0.0009076845,0.0050489977,0.00006052993,0.0105232,0.93606234,0.00075079437,0.028663049,0.000039207684],"about_ca_topic_score_codex":0.00012420559,"about_ca_topic_score_gemma":0.00017034312,"teacher_disagreement_score":0.0021871638,"about_ca_system_score_codex":0.00018840955,"about_ca_system_score_gemma":0.00034396947,"threshold_uncertainty_score":0.007316768},"labels":[],"label_agreement":null},{"id":"W2087333240","doi":"10.1097/cji.0b013e31803240fa","title":"Human Papillomavirus 16 E6-specific CD45RA+ CCR7+ High Avidity CD8+ T Cells Fail to Control Tumor Growth Despite Interferon-γ Production in Patients With Cervical Cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Human papillomavirus; Avidity; Medicine; CD8; Cervical cancer; Interferon; Interferon γ; Cancer research; Immunology; Interferon gamma; Cancer; Cytokine; Internal medicine; Immune system; Antigen","score_opus":0.007814464370940874,"score_gpt":0.236006648320105,"score_spread":0.22819218394916413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087333240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990306,0.00032887503,0.000073608826,0.000030453451,0.0000056512085,0.0000126041705,0.000034556168,0.000008814978,0.0004749084],"genre_scores_gemma":[0.9995679,0.000064937434,0.000041029685,0.000031881355,0.000007176949,0.000006954207,0.000059318347,0.000002030045,0.00021882553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998491,0.000025354408,0.000014795359,0.00004427875,0.000024437148,0.000042043353],"domain_scores_gemma":[0.99973315,0.00008424281,0.00005806164,0.000029424373,0.000029274768,0.00006584217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017490887,0.00029103857,0.00043800927,0.000334659,0.00034363367,0.0004427337,0.00015398013,0.00046305315,0.0011337595],"category_scores_gemma":[0.0008492388,0.00024611785,0.00016474405,0.00022040938,0.00024308285,0.00021076627,0.00014122351,0.00033250154,0.00026102876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005558568,0.0006292807,0.8508922,0.00010133012,0.000090641275,0.005410198,0.0007892283,0.00040864246,0.099683754,0.00008763146,0.0003521017,0.03599644],"study_design_scores_gemma":[0.00021362962,0.0040419046,0.9689584,0.000018905619,0.00016576168,0.012026292,0.00036130368,0.0011272342,0.010651616,0.00011116017,0.002308609,0.000015291544],"about_ca_topic_score_codex":0.0014972992,"about_ca_topic_score_gemma":0.0012402756,"teacher_disagreement_score":0.0014972992,"about_ca_system_score_codex":0.0003610706,"about_ca_system_score_gemma":0.00016764714,"threshold_uncertainty_score":0.0037928224},"labels":[],"label_agreement":null},{"id":"W2111152776","doi":"10.1097/cji.0b013e3181b290f1","title":"Therapeutic (High) Doses of Rituximab Activate Calcium Mobilization and Inhibit B-cell Growth via an Unusual Mechanism Triggered Independently of Both CD20 and Fcγ Receptors","year":2009,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Monoclonal antibody; CD20; Chemistry; Calcium in biology; Rituximab; Intracellular; Cytotoxic T cell; Cell biology; Receptor; Monoclonal; Antibody; Cancer research; Pharmacology; Immunology; Biology; Biochemistry; In vitro","score_opus":0.017812890456479578,"score_gpt":0.2976385071035246,"score_spread":0.279825616647045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111152776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861843,0.0050546345,0.005864756,0.000257401,0.000044024197,0.000052816387,0.00008718562,0.00014388002,0.0023110837],"genre_scores_gemma":[0.9966324,0.00083251327,0.0018076624,0.00009249093,0.000037226793,0.00002847225,0.00007690089,0.000011409538,0.00048104557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984336,0.000035675945,0.000007580397,0.00001930676,0.00004504068,0.000048992944],"domain_scores_gemma":[0.999926,0.00002416124,0.000016392385,0.0000121062985,0.0000058882556,0.000015415706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014991743,0.00028067996,0.0003290815,0.00017669392,0.000115948635,0.00031377407,0.0002583902,0.0004424255,0.0009245053],"category_scores_gemma":[0.00020850582,0.00010991702,0.0001653036,0.0001128826,0.00024960635,0.00018407799,0.00021132709,0.00062536786,0.00024495856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014346404,0.000051215964,0.00009711197,0.000035426765,0.0000065013087,0.00009900383,0.000013449075,0.000112664224,0.99643034,0.00021139214,0.000077864635,0.002721528],"study_design_scores_gemma":[0.000108904365,0.0011003085,0.0020209409,0.0000068223403,0.00003722757,0.0008020411,0.000016384436,0.0010537943,0.99204165,0.00019096331,0.002616418,0.0000044192498],"about_ca_topic_score_codex":0.00013396308,"about_ca_topic_score_gemma":0.00027182346,"teacher_disagreement_score":0.0009245053,"about_ca_system_score_codex":0.00027055733,"about_ca_system_score_gemma":0.00013203971,"threshold_uncertainty_score":0.0030927658},"labels":[],"label_agreement":null},{"id":"W2151605250","doi":"10.1097/01.cji.0000175685.36239.e5","title":"SSX Cancer Testis Antigens are Expressed in Most Multiple Myeloma Patients","year":2005,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Antigen; Multiple myeloma; Malignancy; Medicine; Cancer; Bone marrow; Synovial sarcoma; Immunohistochemistry; Reverse transcription polymerase chain reaction; Cancer research; Pathology; Internal medicine; Gene; Gene expression; Sarcoma; Immunology; Biology","score_opus":0.011048643253851125,"score_gpt":0.25108637517257176,"score_spread":0.24003773191872063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151605250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983852,0.00072626915,0.00016266176,0.00003426219,0.0000033501383,0.0000043208183,0.00017353609,0.000012229103,0.0004982596],"genre_scores_gemma":[0.99902725,0.00017427711,0.00013758308,0.000025619116,0.000007458482,0.0000030368274,0.00021060219,0.0000014769886,0.00041265218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998741,0.000021055017,0.000012378149,0.000033650955,0.00003721714,0.000021582584],"domain_scores_gemma":[0.9998522,0.000026279246,0.000069470785,0.000008858244,0.000020986276,0.000022161234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096894786,0.00015462677,0.00017997119,0.00034033362,0.00016752379,0.00018687037,0.000062956286,0.0001727688,0.0014973931],"category_scores_gemma":[0.00034427192,0.000060319166,0.00012857397,0.0003759047,0.00012035847,0.00010635491,0.000104753446,0.0001804265,0.00014919059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052941416,0.000029446737,0.8986169,0.000051612864,0.00006110934,0.0007161504,0.0001510058,0.00011103084,0.08378281,0.000080153004,0.0002708187,0.015599416],"study_design_scores_gemma":[0.000008071204,0.00028633315,0.9861703,0.000007217297,0.000041315005,0.0036176716,0.00010208053,0.00017485193,0.007999883,0.000063063075,0.0015265764,0.0000027931667],"about_ca_topic_score_codex":0.0008593075,"about_ca_topic_score_gemma":0.00071969244,"teacher_disagreement_score":0.0014973931,"about_ca_system_score_codex":0.00012737831,"about_ca_system_score_gemma":0.000089372,"threshold_uncertainty_score":0.005009234},"labels":[],"label_agreement":null},{"id":"W2313266659","doi":"10.1097/cji.0000000000000115","title":"Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance","year":2016,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Trastuzumab; Conjugate; Antibody-drug conjugate; In vivo; Potency; In vitro; Pharmacology; Medicine; Antibody; Cytotoxicity; Cancer research; Monoclonal antibody; Cancer; Immunology; Breast cancer; Biology; Internal medicine; Biochemistry","score_opus":0.014081031302336728,"score_gpt":0.28043528824367997,"score_spread":0.26635425694134324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313266659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966246,0.00082611205,0.0014242247,0.000045976223,0.000008561891,0.000024637196,0.000029681933,0.000029368488,0.000986853],"genre_scores_gemma":[0.9973573,0.0005445346,0.0009973657,0.000026565502,0.0000032771293,0.000009551604,0.00006674001,0.000005937172,0.0009885562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999242,0.000012327404,0.0000055037735,0.000014317096,0.00001796873,0.000025693229],"domain_scores_gemma":[0.9999721,0.0000046388795,0.00000910309,0.000003301193,0.000004315713,0.0000065767367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008145895,0.00032422313,0.00026662502,0.00018555064,0.00008482204,0.0001921269,0.000127588,0.00020553006,0.0003729714],"category_scores_gemma":[0.00008325418,0.00009666582,0.00015327538,0.00012437683,0.000107253996,0.00018022672,0.00018536304,0.00034729135,0.0000801268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008726724,0.000042127256,0.00022751228,0.000027981378,0.000007558413,0.000041921503,0.000009690914,0.00030622949,0.99438184,0.00014280311,0.00002864573,0.004696379],"study_design_scores_gemma":[0.000021573744,0.00059055205,0.0015161224,0.0000027162375,0.000013437332,0.00020673133,0.0000053480353,0.0012445109,0.9947613,0.000023711844,0.0016111158,0.0000029323464],"about_ca_topic_score_codex":0.0004779411,"about_ca_topic_score_gemma":0.00066718506,"teacher_disagreement_score":0.0004779411,"about_ca_system_score_codex":0.00030394318,"about_ca_system_score_gemma":0.00015125351,"threshold_uncertainty_score":0.0022052526},"labels":[],"label_agreement":null},{"id":"W2317490780","doi":"10.1097/cji.0b013e3181eccc87","title":"Preclinical Qualification of a New Multi-antigen Candidate Vaccine for Metastatic Melanoma","year":2010,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Learning Partnership; Sanofi (Canada)","funders":"","keywords":"Antigen; Immunogenicity; Immunology; Immune system; Cytotoxic T cell; Antigen presentation; Biology; Melanoma; Ex vivo; Medicine; T cell; Cancer research; Virology; In vitro","score_opus":0.04058313421163846,"score_gpt":0.3532582963415023,"score_spread":0.31267516212986385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317490780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98305213,0.0023289642,0.010931747,0.00020231215,0.00014296612,0.0007756046,0.00038945623,0.00010989141,0.0020669352],"genre_scores_gemma":[0.98492926,0.0019098074,0.009051583,0.00009744072,0.000053955504,0.00035141662,0.00080739654,0.000027019581,0.0027719527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998292,0.000048856476,0.000009892154,0.000024276806,0.000050802504,0.0000369692],"domain_scores_gemma":[0.99987555,0.000022714321,0.000022945474,0.000017225288,0.000025444195,0.00003612616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004186901,0.00044010588,0.00028246894,0.00023466504,0.00010823013,0.00032990164,0.00026001135,0.0005788664,0.0014674957],"category_scores_gemma":[0.00021428622,0.00013328853,0.0002692652,0.00007495115,0.00014776179,0.00027309865,0.0001759659,0.0008525151,0.00036951865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020844593,0.00043304873,0.00023449396,0.00008010245,0.00001267105,0.000039894527,0.000016893906,0.0006047612,0.9934481,0.00014377153,0.00009126376,0.004686651],"study_design_scores_gemma":[0.00016882957,0.025402287,0.001666249,0.00003138125,0.00006229448,0.0003337132,0.00002441393,0.002390775,0.96269536,0.00014568669,0.0070722112,0.000006734036],"about_ca_topic_score_codex":0.00024407452,"about_ca_topic_score_gemma":0.00032927416,"teacher_disagreement_score":0.0014674957,"about_ca_system_score_codex":0.00020636483,"about_ca_system_score_gemma":0.00025748397,"threshold_uncertainty_score":0.004909277},"labels":[],"label_agreement":null},{"id":"W2324509048","doi":"10.1097/cji.0b013e3182a801f2","title":"Antitumor Impact of Interferon-γ Producing CD1d-restricted NKT Cells in Murine Malignant Mesothelioma","year":2013,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"Mesothelioma Applied Research Foundation","keywords":"CD1D; Mesothelioma; Natural killer T cell; Interferon; Interferon γ; Medicine; Cancer research; Immunology; Interferon gamma; Pathology; Immune system; T cell","score_opus":0.008736423010468595,"score_gpt":0.2684745100164579,"score_spread":0.25973808700598927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324509048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774075,0.00069882703,0.0005638382,0.000055513563,0.000026841122,0.000029184763,0.00017052643,0.00005879852,0.00065570633],"genre_scores_gemma":[0.9977684,0.00042271763,0.0007456846,0.000028051594,0.000013655918,0.000037867612,0.00017991252,0.000010287023,0.0007934021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998357,0.00003140163,0.000025872778,0.000031132367,0.0000328634,0.000042938296],"domain_scores_gemma":[0.9998833,0.000016651118,0.000033485598,0.000022249,0.000008705709,0.00003559954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016024621,0.00045556162,0.0003541148,0.00033256243,0.00013841344,0.00022877897,0.00014391926,0.00031931227,0.0005263072],"category_scores_gemma":[0.00013615235,0.0001590215,0.00026517897,0.00012514727,0.0002150509,0.00019480441,0.00015331674,0.00067975477,0.00024667225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000474779,0.00018671302,0.0003120673,0.00004397144,0.000005066845,0.000076001554,0.000027058852,0.00021333323,0.9969879,0.000039837254,0.000026973314,0.0016063527],"study_design_scores_gemma":[0.00015146649,0.0034621744,0.0047039697,0.0000104512665,0.00003353386,0.00036843127,0.000037692058,0.0017947004,0.988309,0.00006731253,0.0010555602,0.0000055861738],"about_ca_topic_score_codex":0.00024812503,"about_ca_topic_score_gemma":0.0002876047,"teacher_disagreement_score":0.0005263072,"about_ca_system_score_codex":0.00018625383,"about_ca_system_score_gemma":0.00016189893,"threshold_uncertainty_score":0.0017606616},"labels":[],"label_agreement":null},{"id":"W2328883326","doi":"10.1097/cji.0b013e3181fe535b","title":"Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade","year":2010,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut Gustave-Roussy; Institut National Du Cancer","keywords":"CD80; Dendritic cell; CD86; CD8; Microvesicles; T cell; Immune system; Immunotherapy; Immunology; Cancer research; Medicine; Chemistry; CD40; In vitro; Cytotoxic T cell; microRNA; Biochemistry","score_opus":0.010022400704014693,"score_gpt":0.31838417230397276,"score_spread":0.3083617715999581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328883326","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18852468,0.022726065,0.74392444,0.0023960536,0.001349989,0.006047076,0.0044047865,0.00327379,0.027353188],"genre_scores_gemma":[0.3410229,0.020730102,0.5850046,0.0010055193,0.000511064,0.0037535387,0.011250481,0.00088647235,0.03583536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987312,0.00021342559,0.00017514471,0.00019621603,0.0006157591,0.00006820906],"domain_scores_gemma":[0.9994598,0.000064872045,0.0001109841,0.00014347158,0.00015906792,0.00006174086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019500026,0.0008967679,0.00054749707,0.0014769033,0.0004450313,0.0011705897,0.00060077856,0.0009293561,0.0046056597],"category_scores_gemma":[0.0011582457,0.00047031936,0.00073638855,0.00088040496,0.00039458353,0.0008045193,0.00079302565,0.0015971283,0.004324023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012651486,0.00018789852,0.00048507447,0.00026043053,0.000019624302,0.00012266077,0.00006394389,0.00022730301,0.93566537,0.0013166856,0.0012658505,0.06025865],"study_design_scores_gemma":[0.00009983757,0.0005906857,0.0018982165,0.000049299935,0.000095638075,0.0011861433,0.00003048686,0.00066047505,0.9160686,0.0005277294,0.078762494,0.000030374318],"about_ca_topic_score_codex":0.00027700595,"about_ca_topic_score_gemma":0.00036520144,"teacher_disagreement_score":0.0046056597,"about_ca_system_score_codex":0.0004659515,"about_ca_system_score_gemma":0.0008327827,"threshold_uncertainty_score":0.015407443},"labels":[],"label_agreement":null},{"id":"W2331816454","doi":"10.1097/cji.0b013e31828eed62","title":"Identification of Synthetic Peptides that Inhibit Lipopolysaccharide (LPS) Binding to Myeloid Differentiation Protein-2 (MD-2)","year":2013,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Lipopolysaccharide; TLR4; Peptide; Peptide library; Tumor necrosis factor alpha; Phage display; Chemistry; Peptide sequence; Receptor; Molecular biology; Biology; Biochemistry; Immunology; Gene","score_opus":0.009315536270661534,"score_gpt":0.22712660890450412,"score_spread":0.21781107263384258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331816454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887694,0.002711886,0.0069045657,0.00009066571,0.000033075936,0.00013259528,0.00038178207,0.00004347277,0.0009324186],"genre_scores_gemma":[0.9713316,0.002786794,0.021734862,0.00021892965,0.00004047521,0.00018896075,0.0018839765,0.00002769023,0.001786678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988043,0.000018298091,0.000010460498,0.000022611295,0.000041305007,0.000026782882],"domain_scores_gemma":[0.9998791,0.000027805912,0.00003465158,0.0000066409893,0.000018043267,0.000033769626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015442653,0.00053848943,0.00046892444,0.00025946184,0.00014762675,0.0002686649,0.00023744344,0.00031416977,0.00085863756],"category_scores_gemma":[0.00019046306,0.0001596211,0.00032435142,0.0002266804,0.0001415796,0.00017545088,0.00021367942,0.00050567125,0.000357384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000840275,0.000047780228,0.00011825799,0.000034599623,0.000004208858,0.00004743196,0.0000044021676,0.000089593996,0.99819225,0.000018757153,0.000016737427,0.0013420888],"study_design_scores_gemma":[0.000057908255,0.0017762445,0.0049846354,0.000013326116,0.000039719678,0.0011945032,0.000024939616,0.0014399868,0.9873976,0.000051267823,0.003007529,0.0000123257105],"about_ca_topic_score_codex":0.00011007383,"about_ca_topic_score_gemma":0.00022240236,"teacher_disagreement_score":0.00085863756,"about_ca_system_score_codex":0.00017117072,"about_ca_system_score_gemma":0.00017145216,"threshold_uncertainty_score":0.0028724074},"labels":[],"label_agreement":null},{"id":"W2468294668","doi":"10.1097/cji.0000000000000131","title":"An Association Between Glatiramer Acetate and Malignant Melanoma","year":2016,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glatiramer acetate; Medicine; Melanoma; Dermatology; Association (psychology); Oncology; Internal medicine; Cancer research; Psychology; Disease","score_opus":0.008823298688931851,"score_gpt":0.24556153186318544,"score_spread":0.23673823317425358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468294668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936407,0.0019008641,0.00041459792,0.000545591,0.000048981583,0.00002116301,0.00006762031,0.000052700536,0.0033077477],"genre_scores_gemma":[0.9990772,0.0003788875,0.00012728365,0.00006162958,0.000059506412,0.0000020655682,0.000018955578,0.0000026368978,0.00027176147],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998098,0.000034219487,0.000019653051,0.0000395114,0.0000363638,0.00006041674],"domain_scores_gemma":[0.9994199,0.0001954473,0.00016647078,0.000056176148,0.000033003787,0.00012902667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018578717,0.00043077837,0.00030426905,0.0009493881,0.00079672504,0.0003739726,0.0002738005,0.0012251694,0.0020660588],"category_scores_gemma":[0.001111043,0.0002763333,0.00029136369,0.0005928823,0.0004691252,0.0004163724,0.000306279,0.0009024935,0.0003761327],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006343636,0.00027831874,0.21274257,0.000073505515,0.000047462436,0.76726365,0.0003855338,0.00014717522,0.00989832,0.00039024616,0.00059088384,0.0075478745],"study_design_scores_gemma":[0.00003062244,0.00038018185,0.11375374,0.000019748908,0.00006245953,0.8807065,0.00017157766,0.0006521585,0.0020453616,0.00026483662,0.0018966205,0.00001614645],"about_ca_topic_score_codex":0.0009155274,"about_ca_topic_score_gemma":0.00088426046,"teacher_disagreement_score":0.0020660588,"about_ca_system_score_codex":0.00026355172,"about_ca_system_score_gemma":0.00020917229,"threshold_uncertainty_score":0.0069116354},"labels":[],"label_agreement":null},{"id":"W2514926023","doi":"10.1097/cji.0000000000000134","title":"Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns","year":2016,"lang":"en","type":"review","venue":"Journal of Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Chimeric antigen receptor; Immunotherapy; Suicide gene; Cancer immunotherapy; Immune system; Cancer; Antigen; Cancer cell; Medicine; Cancer research; Haematopoiesis; Immunology; Genetic enhancement; Biology; Stem cell; Internal medicine; Gene","score_opus":0.04820959936286296,"score_gpt":0.38546702949439904,"score_spread":0.3372574301315361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514926023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002468073,0.99733365,0.00063058274,0.00029027558,0.00012420387,0.000010655951,0.000007888703,0.000010091816,0.0013458931],"genre_scores_gemma":[0.0014630884,0.9962442,0.0009425819,0.00023499994,0.00010602555,0.000015471023,0.000016640273,0.000003623714,0.00097342924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997205,0.000052286643,0.000028119883,0.00003842579,0.00013962026,0.000020897021],"domain_scores_gemma":[0.9997284,0.00014726268,0.000035234643,0.000014606142,0.00005457732,0.000019896981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092238013,0.00077634695,0.0011329046,0.0022874845,0.00030309416,0.0011143363,0.00080616504,0.0013661478,0.002431186],"category_scores_gemma":[0.00062440423,0.00029082442,0.00052536774,0.0016653563,0.00083459826,0.0015221302,0.0007625003,0.002491412,0.0016782106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042936594,0.0001390318,0.00015070244,0.0131980805,0.000069192174,0.00023816283,0.00011822263,0.0006185273,0.012160428,0.016056145,0.013656118,0.9435524],"study_design_scores_gemma":[0.000016008467,0.00010436742,0.0003410513,0.0016794164,0.000051487314,0.0012684548,0.00005455416,0.00012478417,0.0035369254,0.0031103238,0.98969567,0.000016956934],"about_ca_topic_score_codex":0.0005564542,"about_ca_topic_score_gemma":0.00090506783,"teacher_disagreement_score":0.002431186,"about_ca_system_score_codex":0.0006390699,"about_ca_system_score_gemma":0.0008408805,"threshold_uncertainty_score":0.008133113},"labels":[],"label_agreement":null},{"id":"W2620810545","doi":"10.1097/cji.0000000000000153","title":"Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix","year":2017,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"Novo Nordisk Fonden; Faculty of Health and Medical Sciences, University of Western Australia; Lundbeckfonden","keywords":"Antigen; Virology; Adjuvant; Immunology; Biology; Vaccination; Immune system; Cervical cancer; Immunity; Cancer; HPV infection; Vaccine efficacy; Medicine; Genetics","score_opus":0.03189571666955576,"score_gpt":0.36957659373390883,"score_spread":0.33768087706435307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620810545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968954,0.008839496,0.0138632525,0.0005028154,0.00017638296,0.00027490724,0.0005342584,0.00037006606,0.006484752],"genre_scores_gemma":[0.98392224,0.00483452,0.006675071,0.00021437366,0.000065374654,0.00024068796,0.0008398882,0.000029849516,0.0031780163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998939,0.000019017936,0.0000048907914,0.000022137021,0.000028628752,0.000031441814],"domain_scores_gemma":[0.99993825,0.000010805656,0.000011387085,0.000011675368,0.000009735257,0.00001800638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002127812,0.00046040883,0.00040315627,0.00024556371,0.00017910702,0.00025172357,0.00027142206,0.00050163834,0.0016740727],"category_scores_gemma":[0.00023015778,0.00015100362,0.00025412682,0.00015206057,0.0002662366,0.00018665011,0.00024250898,0.00077857176,0.00037709306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022240853,0.0001385591,0.0002817455,0.00014895477,0.000015838144,0.000105521445,0.000036863406,0.00051594316,0.98551184,0.00046154618,0.00027981965,0.012280914],"study_design_scores_gemma":[0.00029343867,0.0074669356,0.0058556497,0.0001490407,0.00014427621,0.0034369992,0.000097159274,0.003560204,0.9326322,0.0013055053,0.045036796,0.000021789974],"about_ca_topic_score_codex":0.00044400964,"about_ca_topic_score_gemma":0.00047394418,"teacher_disagreement_score":0.0016740727,"about_ca_system_score_codex":0.00036620602,"about_ca_system_score_gemma":0.00035544133,"threshold_uncertainty_score":0.005600393},"labels":[],"label_agreement":null},{"id":"W2769377954","doi":"10.1097/cji.0000000000000192","title":"Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood are Cytotoxic Against Primary Breast Cancer Cells","year":2017,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Ex vivo; Immunology; Cancer research; Cytotoxic T cell; Immunotherapy; Cord blood; Biology; Immune system; Medicine; In vivo; In vitro","score_opus":0.012711771299303416,"score_gpt":0.2528253423525576,"score_spread":0.24011357105325418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769377954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332434,0.00286563,0.0021077087,0.00004532818,0.000049543847,0.000060284132,0.00022997585,0.00005020828,0.0012670167],"genre_scores_gemma":[0.9945011,0.0007285579,0.0014634781,0.00006415349,0.000015650163,0.000057422312,0.00083871937,0.0000131375755,0.002317768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998698,0.000017462075,0.000015982861,0.00002621708,0.000042554762,0.000027968494],"domain_scores_gemma":[0.99988556,0.00002767936,0.000018104021,0.000023627028,0.000023324947,0.000021699523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017560889,0.00025221438,0.00025437045,0.0001138412,0.00008527093,0.00025058186,0.00020768003,0.00014248714,0.0012559246],"category_scores_gemma":[0.00016452726,0.000056445533,0.00016125248,0.000110991125,0.00014286466,0.0001651977,0.00018083607,0.00050961046,0.00032761178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003460701,0.000088451896,0.000940194,0.000057263118,0.000010281478,0.00012885849,0.000062964515,0.00011237791,0.9925644,0.000041343414,0.00008827206,0.0055595194],"study_design_scores_gemma":[0.00004202385,0.001153423,0.020775678,0.00002388827,0.00006466622,0.00078529393,0.00006559586,0.00097527035,0.9714109,0.0000440025,0.0046522445,0.0000070200776],"about_ca_topic_score_codex":0.00047545845,"about_ca_topic_score_gemma":0.00089985185,"teacher_disagreement_score":0.0012559246,"about_ca_system_score_codex":0.00016088801,"about_ca_system_score_gemma":0.00014637852,"threshold_uncertainty_score":0.0042015314},"labels":[],"label_agreement":null},{"id":"W2778853333","doi":"10.1097/cji.0000000000000208","title":"Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice","year":2017,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Heterologous; Vaccination; Priming (agriculture); Virology; Virus; Immune system; Biology; Antigen; Adjuvant; Immunology","score_opus":0.024945458897702333,"score_gpt":0.33899210261017587,"score_spread":0.31404664371247354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778853333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4789202,0.118563384,0.22769064,0.020122003,0.035701893,0.0013363028,0.004038843,0.0045844675,0.1090423],"genre_scores_gemma":[0.72940105,0.037566885,0.05594489,0.0027376635,0.0043218173,0.00052248454,0.0020405806,0.00033434766,0.16713028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998666,0.000028116056,0.0000060802795,0.000040523042,0.00003540349,0.000023281635],"domain_scores_gemma":[0.9999151,0.000015635289,0.000014544036,0.000013336916,0.0000133747835,0.000027994849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002922885,0.0005704674,0.000305834,0.00026811808,0.0002460017,0.00034707919,0.00025809623,0.000666453,0.006478579],"category_scores_gemma":[0.0001583687,0.00017629859,0.0002264825,0.00015762568,0.0003013458,0.0002925801,0.00019081807,0.0013018077,0.00217043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009745086,0.00024374196,0.0001405574,0.00036935636,0.00002757793,0.00035285496,0.000038750575,0.00029740596,0.93886715,0.0043717455,0.013670059,0.040646266],"study_design_scores_gemma":[0.0001486307,0.0013477771,0.0008591578,0.000024690014,0.000057479403,0.0021258136,0.000021931917,0.0013207687,0.80305845,0.0007194783,0.19029844,0.000017359785],"about_ca_topic_score_codex":0.00022028458,"about_ca_topic_score_gemma":0.00044089239,"teacher_disagreement_score":0.006478579,"about_ca_system_score_codex":0.00031277112,"about_ca_system_score_gemma":0.00029826455,"threshold_uncertainty_score":0.021673024},"labels":[],"label_agreement":null},{"id":"W2788965461","doi":"10.1097/cji.0000000000000216","title":"Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products","year":2018,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"David Geffen School of Medicine, University of California, Los Angeles; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; UCLA AIDS Institute; Center for AIDS Research, University of Washington; Jonsson Comprehensive Cancer Center; Parker Institute for Cancer Immunotherapy","keywords":"Flow cytometry; Ex vivo; T cell; Immunology; T-cell receptor; Transgene; Cell therapy; Cell; Genetically modified mouse; Medicine; Biology; Cancer research; In vivo; Immune system; Biochemistry","score_opus":0.03856796019210099,"score_gpt":0.28483959101902384,"score_spread":0.24627163082692285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788965461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976248,0.00029853752,0.001533801,0.000012445197,0.000006519297,0.000031833373,0.00018252785,0.000022184948,0.00028731188],"genre_scores_gemma":[0.9976222,0.00017099078,0.001285982,0.000033742985,0.0000051642423,0.00005730615,0.00041562848,0.000013416964,0.00039564574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984086,0.000025789155,0.00001541313,0.00003499637,0.000058072874,0.000024874902],"domain_scores_gemma":[0.9997625,0.0000580195,0.000064594584,0.000026659041,0.000052718748,0.0000355266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024107206,0.00013685915,0.00015295797,0.00016376238,0.00005857696,0.00031483904,0.00014212186,0.00014751487,0.00055283395],"category_scores_gemma":[0.00043551472,0.000078316814,0.0001101697,0.00015358905,0.00011385728,0.00016203408,0.00009351001,0.00031397186,0.00014441925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004109013,0.00007317016,0.003699512,0.00001946729,0.000010360063,0.000058259775,0.000057568395,0.00025022295,0.9897317,0.00003693158,0.000041807358,0.0056100087],"study_design_scores_gemma":[0.000028676464,0.002896121,0.058117703,0.000008403147,0.000077598095,0.00054619554,0.00005858915,0.0022853944,0.9346231,0.000043414784,0.0013063106,0.000008545626],"about_ca_topic_score_codex":0.00019699654,"about_ca_topic_score_gemma":0.00016324679,"teacher_disagreement_score":0.00055283395,"about_ca_system_score_codex":0.00011931903,"about_ca_system_score_gemma":0.00008469264,"threshold_uncertainty_score":0.0018494129},"labels":[],"label_agreement":null},{"id":"W2793304410","doi":"10.1097/cji.0000000000000213","title":"The Risk of Diarrhea and Colitis in Patients With Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Diarrhea; Colitis; Discontinuation; Ipilimumab; Relative risk; Gastroenterology; Incidence (geometry); Ulcerative colitis; Oncology; Immunology; Confidence interval; Immunotherapy; Cancer; Disease","score_opus":0.022225291073107372,"score_gpt":0.2951776078196416,"score_spread":0.2729523167465342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793304410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005239581,0.9932289,0.0003240419,0.000166997,0.00009693226,0.00011657668,0.0005777135,0.000013900624,0.00023525477],"genre_scores_gemma":[0.18505923,0.81077206,0.0012315473,0.00087670906,0.00024758163,0.0005169432,0.0009494345,0.000027760992,0.00031863063],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929697,0.0029068028,0.002422047,0.0007981615,0.0006649735,0.00023831506],"domain_scores_gemma":[0.9835682,0.012005411,0.002613789,0.00044877737,0.0011633002,0.00020061534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008074302,0.002090377,0.013403118,0.005847355,0.0005889522,0.002668676,0.0015669842,0.0018415826,0.002943991],"category_scores_gemma":[0.022371564,0.001493465,0.03680481,0.0077052116,0.00050870754,0.0014055269,0.0012629475,0.0018048323,0.0002582934],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015515845,0.000021811687,0.007777742,0.34933472,0.6295216,0.00018641382,0.000077377474,0.0004957455,0.00020352098,0.00011227444,0.00064680004,0.010070447],"study_design_scores_gemma":[0.00032131805,0.000121203164,0.0052290414,0.020119086,0.9722581,0.00015095233,0.000040132272,0.00016326991,0.000084510146,0.0001575051,0.0013330196,0.000021997968],"about_ca_topic_score_codex":0.0070604486,"about_ca_topic_score_gemma":0.014321708,"teacher_disagreement_score":0.013403118,"about_ca_system_score_codex":0.0018074525,"about_ca_system_score_gemma":0.0025915697,"threshold_uncertainty_score":0.042701483},"labels":[],"label_agreement":null},{"id":"W2932040100","doi":"10.1097/cji.0000000000000261","title":"UV Light–inactivated HSV-1 Stimulates Natural Killer Cell–induced Killing of Prostate Cancer Cells","year":2019,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Terry Fox Research Institute","funders":"","keywords":"TLR2; Peripheral blood mononuclear cell; Biology; Interleukin 21; Herpes simplex virus; Cancer research; Innate immune system; Immune system; Chemistry; Virology; T cell; Immunology; Virus","score_opus":0.006944799991391451,"score_gpt":0.2395682443848913,"score_spread":0.23262344439349986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932040100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992269,0.0039994745,0.0013490506,0.00007071058,0.000040796873,0.000036775516,0.00022098879,0.000062405794,0.0019508394],"genre_scores_gemma":[0.9958781,0.0011792483,0.00088276813,0.000045783887,0.000014791439,0.000026128504,0.00032021236,0.000005674912,0.0016471816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998982,0.000023927714,0.0000063939383,0.000016719696,0.000025786452,0.000029015502],"domain_scores_gemma":[0.99996114,0.000011364129,0.0000062143868,0.0000060122343,0.0000043906985,0.0000108691775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006264935,0.00023254509,0.00018616168,0.0001322272,0.000098109034,0.00016882476,0.00008881823,0.00010452514,0.0019910783],"category_scores_gemma":[0.00007546796,0.000065280794,0.00025258353,0.00010613485,0.000101765116,0.00008912672,0.00016442248,0.00032248508,0.00031389765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021151353,0.000094516705,0.0005098697,0.00012332958,0.0000110506435,0.0000739745,0.000036577938,0.00010634909,0.9930616,0.00006513078,0.00009798122,0.005608066],"study_design_scores_gemma":[0.00006906258,0.001747041,0.017597059,0.000014898673,0.000028895161,0.0009998662,0.000073029754,0.0010642636,0.97298527,0.00011064422,0.0052997563,0.0000103027505],"about_ca_topic_score_codex":0.00045390232,"about_ca_topic_score_gemma":0.00069438055,"teacher_disagreement_score":0.0019910783,"about_ca_system_score_codex":0.00013282745,"about_ca_system_score_gemma":0.00018893469,"threshold_uncertainty_score":0.0066607594},"labels":[],"label_agreement":null},{"id":"W2975999637","doi":"10.1097/cji.0000000000000298","title":"Sarcoid-like Reaction Discovered on EBUS-TBNA of Intrathoracic Lymph Nodes During Immunotherapy for Metastatic Melanoma","year":2019,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Melanoma; Immunotherapy; Lymph node; Biopsy; Endobronchial ultrasound; Radiology; Immune system; Oncology; Pathology; Lung cancer; Immunology; Cancer research","score_opus":0.024296157478950146,"score_gpt":0.3287208180704693,"score_spread":0.3044246605915192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975999637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753162,0.006358704,0.004483603,0.0015884379,0.00029679507,0.00023745983,0.00009374658,0.00018768072,0.011437348],"genre_scores_gemma":[0.9976132,0.0007000089,0.0006199281,0.00042590848,0.00015316912,0.000013924591,0.000027238702,0.000010207969,0.00043642585],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99940526,0.000119067285,0.00008459012,0.00014906735,0.000093166695,0.00014882474],"domain_scores_gemma":[0.99893385,0.00037116144,0.00017928239,0.00013729616,0.00007710641,0.00030121862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005690362,0.0008558497,0.00085023715,0.001205336,0.0012041224,0.00090734044,0.0006410879,0.002760043,0.0009942614],"category_scores_gemma":[0.0027062716,0.00060384494,0.00063200854,0.00043351186,0.0012098944,0.0014338755,0.0007134771,0.001887403,0.00051856757],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110136665,0.00005300481,0.022498356,0.000060100934,0.000012448056,0.9687501,0.00047389028,0.0001317996,0.004939807,0.00011347869,0.00019573393,0.0026610408],"study_design_scores_gemma":[0.000018355697,0.00019806277,0.019890346,0.00004067937,0.000027667684,0.9761129,0.00020108302,0.0005570064,0.002041466,0.00014266185,0.0007534741,0.000016344464],"about_ca_topic_score_codex":0.00140581,"about_ca_topic_score_gemma":0.001872799,"teacher_disagreement_score":0.002760043,"about_ca_system_score_codex":0.000812933,"about_ca_system_score_gemma":0.0005313504,"threshold_uncertainty_score":0.005898297},"labels":[],"label_agreement":null},{"id":"W3035205187","doi":"10.1097/cji.0000000000000324","title":"Laryngeal Tuberculosis in a Patient on Avelumab for Metastatic Nasopharyngeal Carcinoma","year":2020,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Infectious Diseases and Tuberculosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Avelumab; Head and neck cancer; Nivolumab; Dysphagia; Immunotherapy; Oncology; Disease; Tuberculosis; Head and neck squamous-cell carcinoma; Internal medicine; Complication; Cancer; Surgery; Pathology","score_opus":0.020776068736206875,"score_gpt":0.2763666499768896,"score_spread":0.25559058124068273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035205187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95300364,0.0062449593,0.0016954251,0.018906001,0.00088762323,0.000272782,0.00031381808,0.00021478107,0.018460894],"genre_scores_gemma":[0.9928288,0.0012792057,0.000695261,0.002723594,0.0006018956,0.000021749438,0.000066093264,0.00002257567,0.0017607732],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994351,0.000059632734,0.00007215224,0.00014110914,0.00009365633,0.00019832114],"domain_scores_gemma":[0.9988041,0.00029560327,0.00015934954,0.000044426262,0.00007639727,0.00062015397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003381351,0.0010570554,0.0014806766,0.0017587804,0.003548378,0.001146427,0.0010641544,0.0063834162,0.0029086096],"category_scores_gemma":[0.0027931437,0.0008183339,0.0013565808,0.0011053781,0.0013454965,0.00230701,0.0009799298,0.004772216,0.00069113105],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059557973,0.000078005025,0.005288766,0.000024993251,0.0000073171223,0.99232787,0.00023605964,0.00008838166,0.00054504944,0.00012088236,0.0003305315,0.00089263805],"study_design_scores_gemma":[0.00002114992,0.00028122653,0.00783262,0.00004626418,0.000019729803,0.9897585,0.00031608233,0.0005712886,0.00038194517,0.00019710594,0.00055205915,0.000022032427],"about_ca_topic_score_codex":0.0069774934,"about_ca_topic_score_gemma":0.0095310975,"teacher_disagreement_score":0.0069774934,"about_ca_system_score_codex":0.002905921,"about_ca_system_score_gemma":0.0013862092,"threshold_uncertainty_score":0.02108401},"labels":[],"label_agreement":null},{"id":"W3036843612","doi":"10.1097/cji.0000000000000325","title":"A Phase I, Dose Escalation, Single Dose Trial of Oral Attenuated Salmonella typhimurium Containing Human IL-2 in Patients With Metastatic Gastrointestinal Cancers","year":2020,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Toxicity; Medicine; Flow cytometry; Adverse effect; Progressive disease; Regimen; Pharmacology; Immunology; Salmonella; Cancer; Internal medicine; Chemotherapy; Biology","score_opus":0.029855969778758852,"score_gpt":0.318312273686907,"score_spread":0.28845630390814814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036843612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690455,0.0005810737,0.00034679234,0.00019806533,0.00007029895,0.000980741,0.00021628402,0.000055773893,0.00064638164],"genre_scores_gemma":[0.9941459,0.00084983645,0.0011971878,0.0003324721,0.00009200932,0.0013230969,0.0005477201,0.000017305045,0.0014944809],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997266,0.00011627749,0.000016098109,0.000041601652,0.000028127215,0.000071290066],"domain_scores_gemma":[0.9996276,0.00007458016,0.000077422956,0.00004949562,0.000026206028,0.00014465908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090119475,0.0015212166,0.0017242129,0.00046140567,0.00040496374,0.0007193335,0.00056952913,0.0010267498,0.0015791624],"category_scores_gemma":[0.0006245667,0.0004953385,0.00087474566,0.00030409766,0.000847336,0.0005807312,0.00026710183,0.0021551033,0.00035214843],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4648613,0.13203077,0.011150421,0.0013661096,0.0012451387,0.00063928997,0.00072986924,0.0066053034,0.23570788,0.00070181146,0.0044341404,0.14052804],"study_design_scores_gemma":[0.18582097,0.7861701,0.010534373,0.000029044657,0.00026412835,0.00030363956,0.00006347701,0.0014245484,0.01332853,0.00017443439,0.0018588856,0.000027904232],"about_ca_topic_score_codex":0.00055869156,"about_ca_topic_score_gemma":0.001440617,"teacher_disagreement_score":0.0017242129,"about_ca_system_score_codex":0.0006854038,"about_ca_system_score_gemma":0.0010489313,"threshold_uncertainty_score":0.0052828193},"labels":[],"label_agreement":null},{"id":"W3064097435","doi":"10.1097/cji.0000000000000337","title":"Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care South East; Queen's University","funders":"","keywords":"Medicine; Immunotherapy; Adverse effect; Cancer; Immune system; Cancer immunotherapy; Oncology; Internal medicine; Immunology","score_opus":0.008550274644871467,"score_gpt":0.25309998093780417,"score_spread":0.2445497062929327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3064097435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834526,0.0010437329,0.00016353952,0.000015904841,0.0000050925137,0.000015474669,0.00010653488,0.000003557562,0.0003008035],"genre_scores_gemma":[0.9995204,0.00013395572,0.000060320155,0.000026148124,0.00001253889,0.000008261414,0.00017556318,0.0000010973782,0.00006166398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993881,0.0001987321,0.000087608365,0.00012434357,0.00013443593,0.0000669131],"domain_scores_gemma":[0.9969324,0.00071919657,0.0017193342,0.00023256666,0.0002010226,0.00019558935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009886661,0.00012762804,0.00041231338,0.00026269778,0.00022710334,0.00030625562,0.00013328585,0.00021171937,0.0003803928],"category_scores_gemma":[0.0023795245,0.000075775235,0.00045220574,0.00039836703,0.00017050366,0.00025667928,0.00018330959,0.00030942855,0.00008504169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011998448,0.000084778156,0.98385966,0.000045381163,0.00008646452,0.00017167635,0.000061295104,0.00016434911,0.0012156257,0.000015893867,0.000054988035,0.013039988],"study_design_scores_gemma":[0.000042622512,0.003865458,0.993258,0.000013049174,0.00009834289,0.001069152,0.00006344373,0.0003254153,0.00047662147,0.000027652992,0.0007539521,0.0000061831042],"about_ca_topic_score_codex":0.00048324504,"about_ca_topic_score_gemma":0.00070274615,"teacher_disagreement_score":0.0009886661,"about_ca_system_score_codex":0.00020305181,"about_ca_system_score_gemma":0.00022445661,"threshold_uncertainty_score":0.005228579},"labels":[],"label_agreement":null},{"id":"W3127379102","doi":"10.1097/cji.0000000000000360","title":"Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced Melanoma","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Western University","funders":"","keywords":"Medicine; Prednisone; Hazard ratio; Internal medicine; Confidence interval; Corticosteroid; Oncology; Immunotherapy; Retrospective cohort study; Cancer; Surgery","score_opus":0.00865073645500127,"score_gpt":0.2852234393671364,"score_spread":0.27657270291213515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127379102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977969,0.0015424185,0.00006207123,0.000043975822,0.000008150488,0.000007137146,0.00014790703,0.000002414759,0.0003890543],"genre_scores_gemma":[0.99966395,0.00013989999,0.000026464793,0.000023025597,0.000011858644,0.0000028147092,0.0000863831,6.6066235e-7,0.000044945074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993376,0.00022012288,0.000096552634,0.00011710534,0.00012976231,0.00009890417],"domain_scores_gemma":[0.99725586,0.0008756726,0.0012029222,0.00015267463,0.00021060664,0.00030213327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005840492,0.00016579752,0.00045763905,0.0003247843,0.00030079295,0.00048582847,0.00015437501,0.000262518,0.0006789086],"category_scores_gemma":[0.0024873896,0.00010924721,0.00036744453,0.00051102525,0.00020414355,0.0003532774,0.00017257601,0.00047923965,0.00010631598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004735083,0.00003918088,0.9970747,0.00001578471,0.000050754577,0.00012490145,0.00002367099,0.000041205254,0.0002976374,0.0000098338105,0.000035485024,0.0018132648],"study_design_scores_gemma":[0.000023447987,0.00062535505,0.9980028,0.000011238873,0.000056252386,0.00069823634,0.000066048415,0.00011612007,0.00013537904,0.000018963097,0.00024161284,0.0000045467827],"about_ca_topic_score_codex":0.0016306263,"about_ca_topic_score_gemma":0.0028574646,"teacher_disagreement_score":0.0016306263,"about_ca_system_score_codex":0.00031596754,"about_ca_system_score_gemma":0.00036972796,"threshold_uncertainty_score":0.0032422543},"labels":[],"label_agreement":null},{"id":"W3172587474","doi":"10.1097/cji.0000000000000377","title":"Safety and Clinical Outcomes of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Diseases","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Cancer; Immunology; Internal medicine","score_opus":0.012997031282716304,"score_gpt":0.3046834379528645,"score_spread":0.2916864066701482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172587474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717003,0.0015352686,0.00009994271,0.00006197653,0.000009510465,0.000011763518,0.0003168948,0.0000030090819,0.0007915739],"genre_scores_gemma":[0.99916506,0.0002739813,0.000040065603,0.000034344786,0.000025742544,0.0000063912253,0.00038653996,9.907192e-7,0.00006676598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897003,0.0002818964,0.00019680292,0.00016315162,0.00025303275,0.00013505599],"domain_scores_gemma":[0.99301106,0.0015131251,0.0040883296,0.00032934768,0.0005017682,0.00055631745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018717384,0.00014088578,0.0004613318,0.0005396643,0.0003001006,0.0005893276,0.00021863988,0.00030979927,0.00070885115],"category_scores_gemma":[0.0062406263,0.00010622487,0.00065854925,0.000919785,0.00029136948,0.00047910563,0.00032618662,0.00049621565,0.00012418379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007381698,0.000048741676,0.99460536,0.000022516235,0.00009797429,0.000059533148,0.000017596807,0.00009175699,0.000104020815,0.000018417095,0.000043196655,0.004152908],"study_design_scores_gemma":[0.000045563876,0.0011542595,0.9976138,0.000012651606,0.00009047764,0.0003830518,0.00004415554,0.0002642562,0.000112340495,0.000043663633,0.00023146531,0.0000044095336],"about_ca_topic_score_codex":0.0008651039,"about_ca_topic_score_gemma":0.0013784604,"teacher_disagreement_score":0.0018717384,"about_ca_system_score_codex":0.00037650307,"about_ca_system_score_gemma":0.0004935544,"threshold_uncertainty_score":0.009898782},"labels":[],"label_agreement":null},{"id":"W3195519455","doi":"10.1097/cji.0000000000000386","title":"Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovative Targeting Solutions (Canada)","funders":"","keywords":"Medicine; Cancer research","score_opus":0.019090535158918856,"score_gpt":0.32822564717479075,"score_spread":0.3091351120158719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195519455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8674471,0.042521466,0.07104365,0.0012750675,0.00018392052,0.0008731577,0.0007427833,0.0009576325,0.014955092],"genre_scores_gemma":[0.951042,0.012385572,0.029541371,0.00036986082,0.000050572202,0.0001954939,0.000536181,0.000077843266,0.0058011496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969256,0.000090767564,0.00001688977,0.00004561965,0.000089809815,0.00006433309],"domain_scores_gemma":[0.99989665,0.000034940225,0.000014624603,0.000010421356,0.00002424769,0.000019106139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006123372,0.0004670183,0.00033381235,0.00042874596,0.00017939074,0.000996857,0.0003151925,0.0005333981,0.0016548141],"category_scores_gemma":[0.00038355018,0.0002274789,0.00023490032,0.00026207286,0.0003396157,0.0006567852,0.00040697987,0.0007106463,0.00071000087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020395087,0.00019076128,0.00058005523,0.00019649805,0.000016542068,0.00013998996,0.00009558893,0.0036263086,0.95176077,0.00366236,0.0007548933,0.038772292],"study_design_scores_gemma":[0.00007151898,0.0012526853,0.00095332356,0.000040236526,0.00004993858,0.00045103813,0.00007458119,0.0069229156,0.96658576,0.00100027,0.022574712,0.000022977125],"about_ca_topic_score_codex":0.00059076055,"about_ca_topic_score_gemma":0.0012932146,"teacher_disagreement_score":0.0016548141,"about_ca_system_score_codex":0.0006584304,"about_ca_system_score_gemma":0.00033925328,"threshold_uncertainty_score":0.005535841},"labels":[],"label_agreement":null},{"id":"W3199751602","doi":"10.1097/cji.0000000000000392","title":"The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Immunotherapy; Hazard ratio; Melanoma; Subgroup analysis; Meta-analysis; Overall survival; Confidence interval; Survival analysis; Biomarker","score_opus":0.009092056313388334,"score_gpt":0.2561128628304968,"score_spread":0.24702080651710845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199751602","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09577801,0.90177065,0.00034675936,0.0003583909,0.000105863495,0.000082985345,0.00096616265,0.000007376032,0.0005836714],"genre_scores_gemma":[0.85025,0.1467429,0.00074979383,0.000530213,0.00028804838,0.00018451155,0.0010383424,0.000006776414,0.00020936808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726605,0.0011057275,0.0008814435,0.00029394808,0.00036717375,0.0000856663],"domain_scores_gemma":[0.9885572,0.008190366,0.0024670043,0.0002158153,0.0004518179,0.00011775846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040318994,0.00033976985,0.0024109052,0.0015533911,0.00014129732,0.00077780534,0.0004596909,0.00059708266,0.0009856485],"category_scores_gemma":[0.0136103965,0.00020164493,0.003257202,0.0021871326,0.0002891049,0.0007840337,0.00033423622,0.0006612549,0.00007378866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018594507,0.0001689352,0.5157745,0.15786731,0.08642398,0.0007957246,0.00036537607,0.0011385796,0.0017576177,0.0003589363,0.00294905,0.2138054],"study_design_scores_gemma":[0.0024132594,0.0024364083,0.79102385,0.024156343,0.16007638,0.0030728485,0.00040710642,0.0011396836,0.0012978975,0.0016161856,0.012225641,0.00013442812],"about_ca_topic_score_codex":0.00080454495,"about_ca_topic_score_gemma":0.0014361611,"teacher_disagreement_score":0.0040318994,"about_ca_system_score_codex":0.00036982226,"about_ca_system_score_gemma":0.00059515936,"threshold_uncertainty_score":0.021322966},"labels":[],"label_agreement":null},{"id":"W3212489268","doi":"10.1097/cji.0000000000000400","title":"Racial Differences in Survival Among Advanced-stage Non–small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB)","year":2021,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"","keywords":"Quartile; Lung cancer; Comorbidity; Hazard ratio; Proportional hazards model; Confidence interval; Psychological intervention; Cancer; National Death Index","score_opus":0.0169396481623604,"score_gpt":0.3064357109546174,"score_spread":0.28949606279225704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212489268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965491,0.00050018914,0.00011594098,0.00009916995,0.000012229125,0.000012549611,0.0024455183,0.0000035896926,0.00026165455],"genre_scores_gemma":[0.9965946,0.00017462275,0.000089212226,0.000056974473,0.000013255788,0.00001662339,0.002960165,0.000003199029,0.000091324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987079,0.00042359126,0.00018741455,0.00027979547,0.00025485657,0.00014646002],"domain_scores_gemma":[0.9979874,0.0004474375,0.00086432823,0.00022591709,0.00025489889,0.00022003017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016627073,0.00017322242,0.00051624223,0.00082218304,0.0003246218,0.000506748,0.00044443674,0.00033273146,0.00094707205],"category_scores_gemma":[0.0034184486,0.00022678461,0.0011999513,0.0017557048,0.00015118848,0.0004566725,0.00060698704,0.000585283,0.00015133286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023273315,0.0000254296,0.998139,0.000014771701,0.00026244915,0.000017431763,0.000037596237,0.000079500736,0.000082421604,0.000023342945,0.00023055606,0.00085476803],"study_design_scores_gemma":[0.000016269132,0.000038072787,0.9988337,0.000005942287,0.00012732364,0.000054872984,0.000079389254,0.00052324706,0.00004150009,0.00002172185,0.00025437167,0.0000036039557],"about_ca_topic_score_codex":0.010455894,"about_ca_topic_score_gemma":0.015324432,"teacher_disagreement_score":0.010455894,"about_ca_system_score_codex":0.00051751436,"about_ca_system_score_gemma":0.00052406185,"threshold_uncertainty_score":0.0207901},"labels":[],"label_agreement":null},{"id":"W4205108774","doi":"10.1097/cji.0000000000000409","title":"Rapid Unmasking of Immune-related Adverse Events After Discontinuation of Chemotherapy in Chemo-immunotherapy Regimens","year":2022,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Pembrolizumab; Discontinuation; Adverse effect; Chemotherapy; Incidence (geometry); Cancer","score_opus":0.008424769347801111,"score_gpt":0.25487114318210635,"score_spread":0.24644637383430523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205108774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964685,0.003369961,0.0013158958,0.00021539113,0.000037234942,0.000083963634,0.000060898998,0.000042427473,0.00522739],"genre_scores_gemma":[0.9987669,0.000382201,0.00022526753,0.00011552807,0.00003393579,0.0000125071365,0.000056980345,0.0000037108787,0.00040292527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996612,0.00007458921,0.00005813758,0.0000444663,0.00008561373,0.00007599829],"domain_scores_gemma":[0.99854517,0.00033063372,0.000841247,0.00008185421,0.00008269991,0.00011844158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026374805,0.00018662128,0.00032864412,0.00029958918,0.00031778528,0.00041483185,0.00017207419,0.0003377538,0.00086460746],"category_scores_gemma":[0.0019731976,0.00011139,0.00030311613,0.00026225232,0.00019055372,0.00022819359,0.00023065468,0.0006080203,0.00020509702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010830067,0.00026820594,0.7787907,0.0001758902,0.000082645274,0.13034669,0.00064164074,0.00036324823,0.015959946,0.0003566762,0.000730579,0.07120088],"study_design_scores_gemma":[0.00005270442,0.0012785367,0.7107601,0.00011566661,0.00010466472,0.2695177,0.00027620172,0.00084955315,0.008264386,0.00026710844,0.0084915105,0.000021876907],"about_ca_topic_score_codex":0.0004996658,"about_ca_topic_score_gemma":0.0008928121,"teacher_disagreement_score":0.00086460746,"about_ca_system_score_codex":0.00031060487,"about_ca_system_score_gemma":0.00022668797,"threshold_uncertainty_score":0.002892375},"labels":[],"label_agreement":null},{"id":"W4220998209","doi":"10.1097/cji.0000000000000418","title":"Immune Checkpoint Inhibitor Exposure in Pregnancy: A Scoping Review","year":2022,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunotherapy; Immune system; Programmed cell death; Cytotoxic T cell; Pregnancy; PD-L1; Blocking antibody; Immune tolerance","score_opus":0.023117914531586993,"score_gpt":0.31771295154624396,"score_spread":0.29459503701465695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220998209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003584663,0.9987375,0.00006622803,0.0002268744,0.000084363106,0.00002060484,0.00007667756,0.0000028687953,0.00042637688],"genre_scores_gemma":[0.0028984866,0.99652076,0.00013638589,0.00017004997,0.000072832714,0.000033724056,0.000075733384,0.000001822469,0.00009020964],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987484,0.0002407618,0.0006287554,0.00011779897,0.00020843153,0.000055827622],"domain_scores_gemma":[0.99195874,0.0061055007,0.0013090539,0.000089140354,0.00045726035,0.00008037278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001463432,0.0007843823,0.0018169398,0.007678592,0.00047583776,0.001469042,0.0009441372,0.0014015603,0.0035113166],"category_scores_gemma":[0.009865228,0.00043041655,0.0018226182,0.008269611,0.00046430132,0.0014430633,0.00075602316,0.00083332206,0.00038602055],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017410058,0.00004340862,0.0024842336,0.46907368,0.0015200428,0.0018063844,0.0005016562,0.000293514,0.00052076316,0.0013038791,0.014591151,0.5076871],"study_design_scores_gemma":[0.000037920876,0.00010677876,0.005245403,0.7568985,0.0065025496,0.007209589,0.00050502113,0.00013540442,0.00046342483,0.0008936534,0.22195776,0.00004386896],"about_ca_topic_score_codex":0.0034907782,"about_ca_topic_score_gemma":0.0048723277,"teacher_disagreement_score":0.007678592,"about_ca_system_score_codex":0.0011822974,"about_ca_system_score_gemma":0.0042064684,"threshold_uncertainty_score":0.011746526},"labels":[],"label_agreement":null},{"id":"W4223419842","doi":"10.1097/cji.0000000000000416","title":"Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience","year":2022,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Food and drug administration; Neurotoxicity; Clinical trial; Lymphoma; Chimeric antigen receptor; Retrospective cohort study; Human immunodeficiency virus (HIV)","score_opus":0.024638429068061577,"score_gpt":0.2989431095813114,"score_spread":0.2743046805132498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223419842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952507,0.002516217,0.00022920022,0.00028952767,0.000023841496,0.00007098815,0.000095031064,0.000006149864,0.001518241],"genre_scores_gemma":[0.9973694,0.0014462466,0.00032769784,0.00024409499,0.000057937395,0.000053171214,0.00026552312,0.0000050345693,0.00023094473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995666,0.00025526356,0.00003268536,0.00005478572,0.000039628645,0.000051013336],"domain_scores_gemma":[0.9995734,0.00011453586,0.00007523439,0.0000490979,0.000026060881,0.00016167494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011199601,0.00028476326,0.0004939076,0.00016606301,0.00035358334,0.00061972614,0.0002532783,0.000295138,0.0008590815],"category_scores_gemma":[0.0014166819,0.000105357816,0.00030152223,0.00028759867,0.00037164596,0.00047111354,0.00029914937,0.0005866815,0.00024542422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07347696,0.01742268,0.48528245,0.0004834455,0.00077672687,0.01044328,0.0023367223,0.0020727427,0.030635739,0.0010775628,0.008118174,0.36787343],"study_design_scores_gemma":[0.042965446,0.2630932,0.5904963,0.00041680437,0.0012190717,0.03794234,0.0024202066,0.0056052315,0.013106998,0.0013729316,0.041235432,0.0001260445],"about_ca_topic_score_codex":0.000639345,"about_ca_topic_score_gemma":0.0012663713,"teacher_disagreement_score":0.0011199601,"about_ca_system_score_codex":0.0005342392,"about_ca_system_score_gemma":0.0004934918,"threshold_uncertainty_score":0.005922973},"labels":[],"label_agreement":null},{"id":"W4388493259","doi":"10.1097/cji.0000000000000492","title":"Effectiveness and Safety of Immune Checkpoint Inhibitors in Cancer Patients With Autoimmune Disease: A Retrospective Cohort Study","year":2023,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; CancerCare Manitoba; Manitoba Health; University of Manitoba","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Retrospective cohort study; Odds ratio; Adverse effect; Proportional hazards model; Cancer; Cohort; Logistic regression; Confidence interval; Oncology; Surgery","score_opus":0.006176008549061644,"score_gpt":0.2705369440056471,"score_spread":0.26436093545658546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388493259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983334,0.0006521903,0.0001354674,0.000020794661,0.000006994288,0.000024327055,0.0005438204,0.0000027407505,0.00028025126],"genre_scores_gemma":[0.99897647,0.00024483266,0.00008043376,0.000030876974,0.000013051983,0.000017960567,0.0005684596,0.000002187417,0.00006577025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875116,0.0002820207,0.00022617863,0.00037297417,0.00023173427,0.00013587742],"domain_scores_gemma":[0.99665546,0.00055842154,0.0016439348,0.0005055085,0.00035514834,0.0002814716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015400604,0.00023768106,0.0005550568,0.000833664,0.0003824572,0.0007402026,0.00030876254,0.0003716677,0.00091861706],"category_scores_gemma":[0.003104107,0.0003014811,0.0010188392,0.0012824776,0.00025589272,0.00049503363,0.00040329085,0.0005264485,0.00022161008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002219906,0.000020867008,0.99863404,0.000012922178,0.00014294869,0.00006382887,0.000025769328,0.00002666626,0.00008996061,0.000009160444,0.00004409119,0.00070789165],"study_design_scores_gemma":[0.000030777082,0.00040732714,0.9977943,0.000011832875,0.00021847767,0.0007306359,0.00011266716,0.00020646576,0.000098717144,0.000019149937,0.000362139,0.0000075636135],"about_ca_topic_score_codex":0.0022010806,"about_ca_topic_score_gemma":0.0020455148,"teacher_disagreement_score":0.0022010806,"about_ca_system_score_codex":0.00039974548,"about_ca_system_score_gemma":0.00042398984,"threshold_uncertainty_score":0.008144736},"labels":[],"label_agreement":null},{"id":"W4390947852","doi":"10.1097/cji.0000000000000501","title":"Nivolumab in Squamous Cell Carcinomas of the Head and Neck (SCCHN): A Real-world Outcome Study in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Contraindication; Hazard ratio; Head and neck; Oncology; Proportional hazards model; Surgical oncology; Cancer; Surgery; Immunotherapy; Confidence interval; Pathology","score_opus":0.023676190117465627,"score_gpt":0.2972688873823677,"score_spread":0.27359269726490204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390947852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908852,0.0018340634,0.00007962668,0.00037127195,0.000016280837,0.000121752324,0.005206322,0.000009032299,0.0014763785],"genre_scores_gemma":[0.9956169,0.0008886784,0.000084119485,0.0001365256,0.000015858624,0.000034658573,0.002635651,0.0000050254066,0.00058252277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987804,0.000117293246,0.00007003385,0.00020828024,0.00039383094,0.00043007894],"domain_scores_gemma":[0.99741566,0.00010845651,0.0005692951,0.000099588426,0.0011220037,0.00068502873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010507441,0.00059495517,0.0006796534,0.00093322975,0.0024977801,0.0013949057,0.0013558078,0.0006656005,0.0011472326],"category_scores_gemma":[0.0016663643,0.00042062096,0.000770062,0.0037657376,0.001005083,0.00047570895,0.0008778073,0.00072349975,0.00023316566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005714777,0.00011579874,0.99226063,0.00010008281,0.00017247646,0.00018577614,0.00051162334,0.00020311745,0.00034815096,0.0000856827,0.0014475894,0.003997611],"study_design_scores_gemma":[0.00007017682,0.000095513315,0.99796104,0.00003358446,0.000077254896,0.00008167288,0.00043665836,0.0002556098,0.000039758273,0.000017774251,0.0009177274,0.000013359739],"about_ca_topic_score_codex":0.98938423,"about_ca_topic_score_gemma":0.9916299,"teacher_disagreement_score":0.03730509,"about_ca_system_score_codex":0.03730509,"about_ca_system_score_gemma":0.03296361,"threshold_uncertainty_score":0.27066863},"labels":[],"label_agreement":null},{"id":"W4398145149","doi":"10.1097/cji.0000000000000527","title":"False-positive Findings of Large Vessel Vasculitis on FDG-PET in Patients Treated With Immune Checkpoint Inhibitors","year":2024,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Discontinuation; Vasculitis; Positron emission tomography; Radiology; Retrospective cohort study; Immunosuppression; Internal medicine; Nuclear medicine","score_opus":0.005921378093618918,"score_gpt":0.251044565208188,"score_spread":0.2451231871145691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398145149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971048,0.0013528323,0.0003625838,0.00009176057,0.000016538299,0.000016508438,0.000024024539,0.000013284551,0.0010175987],"genre_scores_gemma":[0.9994573,0.00021109107,0.00017593455,0.000054312084,0.000025153402,0.0000030739413,0.000020311361,0.0000033006959,0.00004952038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990095,0.0002880739,0.00016930519,0.0001531108,0.00017269336,0.00020722332],"domain_scores_gemma":[0.9976361,0.0009575729,0.0007586064,0.00018566585,0.00019177995,0.00027021175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010059616,0.00045293005,0.000519417,0.0013814403,0.0006946361,0.000956761,0.0005164596,0.001012044,0.0012028832],"category_scores_gemma":[0.0056140865,0.0005319047,0.00041832862,0.000688465,0.0009108424,0.0006736478,0.00047632764,0.0005990101,0.00025461067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002776531,0.000044081553,0.9224489,0.000036093785,0.000029717248,0.07122529,0.00020324405,0.00011555365,0.0016490236,0.0000351158,0.00013116054,0.0038042648],"study_design_scores_gemma":[0.00003693298,0.00052365224,0.6022562,0.00007033207,0.00016010246,0.39085326,0.00077104993,0.0014749886,0.0028094116,0.00013991659,0.0008799382,0.000024161925],"about_ca_topic_score_codex":0.0015743934,"about_ca_topic_score_gemma":0.0019049965,"teacher_disagreement_score":0.0015743934,"about_ca_system_score_codex":0.0004150316,"about_ca_system_score_gemma":0.00035158455,"threshold_uncertainty_score":0.005320072},"labels":[],"label_agreement":null},{"id":"W4407778016","doi":"10.1097/cji.0000000000000551","title":"The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health Study","year":2025,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; COPD; Internal medicine; Contraindication; Hazard ratio; Lung cancer; Population; Proportional hazards model; Odds ratio; Oncology; Confidence interval; Pathology","score_opus":0.007702180697183973,"score_gpt":0.32121194922370455,"score_spread":0.31350976852652057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407778016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951047,0.0015812516,0.00010840332,0.00022524993,0.000019381634,0.000021522983,0.002160035,0.0000066566063,0.0007728883],"genre_scores_gemma":[0.99863154,0.00021562725,0.000038597278,0.000056233366,0.000018560799,0.000011229836,0.0009152781,0.000002551953,0.000110393026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840814,0.000546849,0.00014463686,0.00034421906,0.00031277246,0.00024339888],"domain_scores_gemma":[0.99681336,0.0006476698,0.0011980829,0.0003520198,0.00046226016,0.0005267165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026022608,0.00032442718,0.0004701848,0.0007442857,0.00053092383,0.0011095824,0.0007337781,0.00090314774,0.0012641642],"category_scores_gemma":[0.0034670855,0.00038153445,0.001777096,0.0019571409,0.00047210365,0.00059633586,0.0006670404,0.0010223819,0.00021950483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021226057,0.000038900816,0.9981364,0.000026606367,0.0005948472,0.00003080626,0.000040803723,0.000036740395,0.000049062677,0.000022740755,0.00018111197,0.0006297382],"study_design_scores_gemma":[0.00001972735,0.00007658488,0.99932325,0.000006623936,0.00018795131,0.00003291297,0.000058303118,0.00012449082,0.0000073819765,0.000016031217,0.00014381993,0.000003081559],"about_ca_topic_score_codex":0.08034522,"about_ca_topic_score_gemma":0.08714903,"teacher_disagreement_score":0.08034522,"about_ca_system_score_codex":0.0014822439,"about_ca_system_score_gemma":0.0017813874,"threshold_uncertainty_score":0.15975511},"labels":[],"label_agreement":null}]}